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ABSTRACT
Trophic changes have been identified by several investigators and associated with 
visceral, articular and neural pathology. There have been claims that trophic changes 
can be used as clinical indicators of pathology of both visceral (Wesselmann and Lai 
1997; Giamberardino et al, 2005; Vecchiet et al, 1990) and somatic structures (Gunn 
and Milbrandt 1978; Galletti et al, 1990), however no sensitivity analysis has been 
conducted in any of the studies so far to substantiate these claims. This dissertation 
consisted of 2 linked studies, both were non-randomized controlled studies, the first 
aimed to investigate the sensitivity of vasomotor, sensory and motor trophic changes 
using tests suitable for clinical practice in subjects with cervical sensory 
radiculopathy (n=31) and frozen shoulder (n=32) (control n=30). The second was a 
controlled study (n=30) which investigated the effect of intra-articular cortico-steroid 
injection on trophic changes in frozen shoulder (n=T7), before and 4 weeks after 
injection. The results showed that though there were significant differences between 
the trophic changes measured in the control and experimental groups, these were not 
sensitive indicators of pathology in frozen shoulder or cervical radiculopathy, 
(vasomotor sensitivity 0.31 and 0.06; sensory sensitivity 0.41 and 0.39; and motor 
sensitivity 0.25 and 0.16, for frozen shoulder and cervical radiculopathy 
respectively). The results o f study 2 also showed that there were no significant 
differences in trophic changes recorded following cortico-steroid injection (P>0.05), 
which suggests that anti-inflammatory medication has no impact on their existence.
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CHAPTER 1
INTRODUCTION AND GENERAL BACKGROUND 
Introduction
This dissertation is a report of 2 linked studies. The first aimed to investigate the 
sensitivity of trophic changes using tests suitable for the clinical environment in 
subjects with cervical sensory radiculopathy and frozen shoulder. The second aimed 
to investigate the effect of cortico-steroid injection on trophic changes in frozen 
shoulder. The studies were experimental, controlled studies with subjects drawn 
from a wide range of primary care medical practitioners in Eastern Birmingham.
This first chapter gives a general background to the study as well as giving an 
overview o f the methodology and the significance o f the study. The second chapter 
discusses the studies which have investigated trophic changes so far, and includes an 
outline o f the aims o f the study. The third chapter describes the methodology in 
detail including participant recruitment, equipment used, reliability analysis, and the 
data reduction and analysis. Chapter 3 also includes justification for the methods and 
equipment used highlighting where other outcome measures were considered but 
rejected. The fourth chapter demonstrates the results and matches the findings to the 
study aims, and Chapter 5 summarises each study and highlights the key findings 
along with the study limitations, ending with the conclusions and recommendations.
General Background
Trophic changes are a collection of vasomotor, sensory and motor signs and 
symptoms which, so far, have not been clearly defined in the literature. It has been 
proposed by many authors that trophic changes are useful as clinical indicators of 
pathology particularly in the field of visceral pathology where referred pain may 
often hinder diagnosis. However these claims are unsubstantiated as none of the 
studies have conducted sensitivity or specificity analysis. Two studies have 
investigated trophic changes in musculoskeletal pathology, but neither study 
considered upper limb or cervical spine pathologies. Subjects with frozen shoulder 
and cervical sensory radiculopathy were considered to be suitable for this study 
because they are conditions which are difficult to differentially diagnose, and if
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trophic changes were shown to be sensitive they would have a high impact in the 
management o f these conditions. In the studies so far, trophic changes have been 
investigated in the area to which pain normally refers. As frozen shoulder and C5 
sensory radiculopathy refer pain into the same segment they were considered ideal 
for this study.
Trophic changes (vasomotor changes in particular) have been strongly correlated 
with experimentally induced inflammation (Wesselmann and Lai 1997), and these 
findings suggest that administration of anti-inflammatory medicine such as cortico­
steroid may bring about a reduction in trophic changes. So far, the effects of anti­
inflammatory medication or other treatments on the existence of trophic changes has 
only been explored by Dragani et al, (1992), and in their study application of anti­
inflammatory medication did indeed reduce the existence of trophic changes. As 
frozen shoulder is an inflammatory condition often treated by intra-articular cortico­
steroid injection, it was considered to be an ideal model to determine whether trophic 
changes were reduced by administration of cortico-steroid.
Aim of Study 1
The purpose of study 1 was to determine whether clinical tests of vasomotor, sensory 
and motor trophic changes were reliable and sensitive clinical indicators o f frozen 
shoulder and cervical radicular pathology.
Aim of Study 2
The purpose of study 2 was to determine whether administration o f intra-articular 
cortico-steroid injection altered trophic changes at the shoulder joint in subjects with 
frozen shoulder.
Overview of the Methodology
To ensure that these tests could be widely employed by clinicians, the methodology 
used was determined by the requirement to be compliant with use in clinical 
environments. In experiment 1, to determine the sensitivity o f trophic changes, 93 
subjects were consecutively recruited from a physiotherapy centre (control group 
n=30, cervical radiculopathy n=31, frozen shoulder n=32). Three outcomes were 
investigated, vasomotor changes were measured with a newly modified technique
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called the modified matchstick test to determine the presence o f subcutaneous 
oedema. Sensory trophic changes were measured with the pressure algometry and 
motor changes were measured with surface electromyography of the maximum 
voluntary contraction. All tests were performed in the C5 dermatome, over the 
deltoid muscle on the lateral aspect o f the shoulder.
In experiment 2, 17 subjects who consented to shoulder joint corticosteroid injection 
were consecutively recruited from the pool of 32 subjects with frozen shoulder in 
experiment 1, and matched to 30 control subjects. Subjects who did not consent to 
an injection but who consented to take part in the study as a further control were also 
recruited (n=10). All subjects underwent the same tests as in experiment 1 at 
baseline, and then at 4 weeks after injection, or at 4 weeks following baseline tests 
for those in the control groups.
Significance of the Study
Upper quadrant conditions such as cervical sensory radiculopathy and frozen 
shoulder are two relatively common conditions that are often difficult to diagnose, 
therefore if trophic change tests were found to be sensitive indicators of pathology 
they could be very useful to a large number of musculoskeletal, general practice, 
rheumatological and orthopaedic clinicians to assist with clinical diagnosis.
The effects o f treatments and medication such as cortico-steroid have not been 
thoroughly investigated however if these treatments were shown to reduce trophic 
changes, they may be useful indicators of recovery and therefore could be of benefit 
both diagnostically and prognostically.
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CHAPTER 2
LITERATURE REVIEW  
Introduction
This chapter introduces the concept of trophic changes and attempts to categorize 
them depending on their underpinning mechanism. Reviewing the literature since 
1975, resulted in five studies which specifically investigated the existence of trophic 
changes, and these are analysed in detail, studies in both animals and humans have 
been included. The first part of this chapter concludes with the summary that in 
general trophic changes have been poorly investigated with methodology that lacks 
reliability or validity, demonstrating the need for further investigation. The 
importance o f trophic changes as diagnostic indicators and their mechanisms are 
discussed in section 2.3 and 2.4, with the literature pertaining to the effects of 
interventions on trophic changes being discussed in section 2.5. The chapter 
concludes with a summary and the study aims. Studies reviewed in section 2.1 to 2.3 
include those which have specifically investigated trophic changes (those studies 
before 1975 have not been included). The studies reviewed in section 2.4, outlining 
the mechanism of trophic changes are drawn from the wider literature.
2.1 Categorization of Trophic Changes
Trophic changes are an ill-defined, collection of vasomotor, sensory and motor signs 
and symptoms, reported to occur in the area to which a pathological structure refers 
pain. Autonomic changes tend to be specifically connected with alterations in 
vasomotor activity and a variety of changes have been investigated such as plasma 
extravasation (Wesselmann and Lai 1997), superficial or subcutaneous oedema 
(Giamberardino et al, 2005; Gunn and Milbrandt 1978) and changes in the flare 
response (Giamberardino et al, 2005; Galletti et al, 1990). Sensory changes such as 
subcutaneous and muscular hyperalgesia have also been reported (Gunn and 
Milbrandt 1978; Giamberardino et al, 2005; Vecchiet et al, 1990), and there have 
been investigations of motor changes, such as muscle spasm (Giamberardino et al, 
2005; Gunn and Milbrandt 1978).
There is debate about whether other autonomic symptoms such as increases in 
pilomotor and sudomotor activity also belong to the family of trophic changes. Gunn
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and Milbrandt (1978) claimed that pilomotor and sudomotor activity may be an 
indicator o f radicular dysfunction, however in their work, Gunn and Milbrandt 
(1978) did not attempt to measure pilomotor or sudomotor changes because they 
reported that they are often only momentary and thus cannot be measured accurately. 
Thus this claim does not arise from experimental evidence but is based on opinion or 
perhaps clinical experience. In contrast, other authors have suggested that with the 
exception of vasomotor activity, autonomic signs such as pilomotor and sudomotor 
activity do not belong to the family o f trophic changes. For example in a review 
paper considering the mechanisms which underpin the symptoms present in complex 
regional pain syndrome patients, Janig and Baron (2003) reported that pilomotor and 
sudomotor changes are not mediated by the same mechanisms as vasomotor activity. 
They reported that increased resting sweat activity cannot be caused by a peripheral 
mechanism because unlike blood vessels, sweat glands do not develop denervation 
supersensitivity (though again the original experimental evidence for this statement 
was not cited). They suggested that re-organisation of central autonomic control is a 
more likely mechanism to explain sudomotor and pilomotor changes, which led 
Janig and Baron (2003) to exclude pilomotor and sudomotor activity from the family 
o f trophic changes. Thus until further work identifying the underpinning mechanisms 
more clearly sudomotor and pilomotor changes were not considered to belong to the 
family of trophic changes and thus were not investigated in this study.
Abnormalities of the skin, subcutaneous tissues, bone, nails and hair may also be 
described as trophic changes or trophoneurotic atrophy (On-line Medical Dictionary 
2005). These changes also tend to be poorly defined, but have generally been 
associated with severe damage to a local peripheral nerve (Sunderland 1991; Janig 
and Baron 2003), though no recent experimental studies were found which 
documented these changes in human subjects with nerve damage. Tissue thickness 
changes such as subcutaneous thickening and muscular thinning have been 
investigated in studies of trophic changes (Vecchiet et al, 1990; Giamberardino et al, 
2005), but the cause of these changes and the underpinning mechanism also appears 
to be unknown, thus making categorization difficult. It is possible that subcutaneous 
thickness and associated muscle thinning may be a combination of trophic changes 
with subcutaneous thickening being suggestive o f vasomotor involvement, and 
muscle thinning being suggestive o f motor changes.
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When searching the wider literature, one experimental animal study was found which 
investigated the development o f epidermal thinning following sensory denervation as 
well as the reversal of thinning following reversal o f nerve crush (Chiang et al,
1998). As these findings are in complete contrast to those proposed by authors of 
trophic change studies, it appears that this is not the mechanism underpinning 
subcutaneous tissue thickness changes (though epidermal and subcutaneous 
mechanisms may not be comparable). Unfortunately the general lack of clarity with 
regards to the underpinning mechanism reduces the value of tissue thickness findings 
because it is unclear what these changes represent. Therefore, for the purpose of this 
study, as with sudomotor and pilomotor changes, tissues thickness changes were not 
investigated.
Therefore for the purpose of this study, the term ‘trophic change’ was used to 
represent vasomotor, sensory or motor signs and symptoms in the area of referred 
pain, but not other autonomic changes such as sudomotor or pilomotor activity, or 
changes in tissue thickness. (N.B. where they have been measured by other authors 
these changes will be highlighted).
2.2 Investigation of Trophic Changes
Trophic changes have been documented to occur in visceral pathology (Wesselmann 
and Lai 1997; Giamberardino et al, 2005; Vecchiet et al, 1990), osteoarthritis 
(Galletti et al, 1990), and nerve root pathology (Gunn and Milbrandt 1978). The 
studies are discussed in detail below, most have measured several changes, often 
investigating one or two from each sub-group (i.e. vasomotor and sensory changes or 
vasomotor and motor changes).
2.2.1 Trophic Changes in Visceral Pathology
Three studies have reported findings of trophic changes in visceral pathology.
Studies in humans have been conducted in gall bladder and renal pathology 
(Giamberardino et al, 2005 and Vecchiet et al, 1990), and there has been one animal 
study which has investigated trophic changes in uterine inflammation (Wesselmann 
and Lai 1997).
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Uterine Inflammation
Wesselman and Lai, (1997) investigated visceral trophic changes using an animal 
model of rat uterine inflammation in 7 experimental and 5 control rats. Uterine 
inflammation was created in the experimental group through injection of mustard oil 
(using a uterine catheter, shown in previous studies to be reliable and valid). Prior to 
the procedure both groups had been injected (through an arterial catheter) with Evans 
blue dye dissolved in sterile water.
Ten minutes following the procedure cutaneous plasma extravasation was shown by 
the presence of Evans blue dye (blue dots) in the area of skin where referred 
hyperalgesia normally occurs (over the abdomen). Skin colour changes were 
quantified by comparing the number of blue dots between the experimental and 
control groups and it was shown that there were significantly more dots in rats with 
inflamed uterine pathology (P<0.05). Though this study shows that a significant 
difference in plasma extravasation between the experimental and control groups 
occurred, the results show that the pattern and number of dots was very variable with 
some rats producing unilateral and some bilateral skin changes. The study reported 
no reliability analysis of the technique used, and therefore it is difficult to be certain 
that this pattern would be repeated consistently such that it could be employed as a 
diagnostic test. Despite these failings, the investigators did ensure that leakage from 
the catheter had not occurred and histology examination demonstrated that 
significant inflammation was found only in uterine tissue, showing that plasma 
extravasation on the abdomen was directly related to the experimentally induced 
uterine inflammation not general abdominal inflammation.
Gall Bladder Pathology
Trophic changes in the form of vasomotor and sensory changes have been measured 
in gallbladder pathology by Giamberardino et al, (2005). In this non-randomized and 
non-blinded study, 4 separate groups of subjects (n=53) with varying degrees of gall 
bladder pathology, (classified on the basis of ultrasound examination), were 
investigated and compared to a control group o f 22 subjects. Vasomotor changes 
were investigated with a method little used called dermographism. This procedure 
entails vertical parallel lines 2 cm apart being traced on the skin surface using the 
blunt point o f a calibrated dermograph at a constant pressure of 500g. According to
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the authors, red lines appear as a consequence of the manoeuvre (a skin flare type 
reaction), which fade away progressively, and simultaneously, in normal skin areas. 
It was reported in this study that an early interruption of these lines occurs in 
hyperalgesic areas, which they defined as ‘the ischaemic phase o f dermographism’. 
The presence o f an ischaemic phase contradicts the findings o f Wesselmann and Lai 
(1997) where plasma extravasation and flare type response is considered to be the 
mechanism that underpins vasomotor changes.
Interestingly the results o f this study showed that early interruption of the skin flare 
reaction following the dermograph procedure did not occur in any of the 5 groups 
tested (nor did it occur in the study by Galletti et al, (1990) -see page 20). The fact 
that an ischaemic reaction following the creation of a flare response has never yet 
been found, coupled with the findings of Wesselmann and Lai (1997), suggests that 
dermographism may not be a useful measure of vasomotor trophic change. 
Vasomotor changes were also investigated with a clinical test called the ‘fovea sign’ 
where tissues are digitally depressed and then observed after a certain time period 
(unspecified) for signs of remaining depression- indicative o f superficial oedema 
(first cited by Galletti et al, 1990). Though this ‘fovea sign’ is reported to be 
indicative o f superficial oedema, original experimental studies showing this finding 
cannot be found and the results of this test were not reported in this study.
Sensory changes (in the form of skin, subcutaneous and muscular hyperalgesia) were 
investigated with a constant current electrical stimulator using 18 ms trains of 0.5 ms 
monophasic square wave pulses, at a frequency o f 310 Hz, repeated automatically 
every 2s. For subcutaneous stimulation a significant effect was observed for the gall 
bladder referral zone, as well as for the severity o f the clinical condition, with 
symptomatic patients demonstrating lower thresholds than asymptomatic and control 
subjects (PO.OOOl). Muscle stimulation also showed significantly lower pain 
thresholds for the gall bladder referral zone and for increasing severity of the clinical 
condition (P<0.001). These results appear to support the suggestion that 
subcutaneous and muscular hyperalgesia are features of visceral pathology, however 
no reliability analysis of the electrical stimulation was conducted in this study (or 
referenced to other work) which would have further strengthened this claim.
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Manual techniques were also used to investigate hyperalgesia. ‘Pinch palpation’ 
(which entails folds of tissue being grasped between the thumb and the index finger 
and pressed together) was used, with hyperalgesia reported if a reaction of 
discomfort was shown by the subject. On analysis o f the results, pinch palpation was 
positive in symptomatic patients and negative in asymptomatic patients and normal 
subjects. However the lack of blinding, reliability analysis or standardisation of 
pressure delivered, demonstrates that these findings cannot be relied up. 
Giamberardino et al, (2005) also highlighted the appearance o f muscle spasm, but 
did not formally measure it.
In this study, tissue thickness was also measured bilaterally with ultrasound 
(however no equipment reliability was performed). Thickness measurements were 
made at the cystic point, the area to which the gall bladder commonly refers pain 
sensation. The results showed that subcutaneous tissue thickness measurements were 
significantly increased in symptomatic patients, along with significantly reduced 
muscle thickness, when compared to asymptomatic patients. Interestingly the study 
found that when testing these patients over a number o f months the subcutaneous and 
muscle changes correlated to the greater number o f painful episodes rather than to 
the degree o f gall bladder dysfunction. However as discussed earlier the lack of 
clarity with regards to the underpinning mechanism means that it is difficult to draw 
conclusions about these findings.
Renal Pathology
Vecchiet et al, (1990) investigated trophic changes in visceral pathology in a small 
non-blinded, non-randomized, non-controlled study, using a group o f 9 patients with 
renal pathology which were split into 2 groups depending on the number o f attacks 
o f renal colic (5 in group 1, with 1-2 attacks, and 4 in group 2, with 4-6 attacks). 
Sensory trophic changes were investigated in the form of hyperalgesic responses to 
manual palpation, mechanical pressure and electric stimulation. The ‘pincer 
palpation’ technique was used as in the study by Giamberardino et al, (2005) to 
determine subcutaneous and muscular hyperalgesia, but the exact method was not 
clearly described. It was reported that all patients had a hyperalgesic response to 
digital palpation, and as in gall bladder pathology, hyperalgesia was reported to be 
more ‘accentuated’ in those suffering from more attacks (group 2). Along with the
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unclear methodology, unfortunately there was also no data analysis presented such 
that it was difficult to analyse the significance of the results summarised in the 
discussion.
Electrical stimulation was also used to measure hyperalgesia in the obliqus externus 
muscle and the overlying subcutaneous tissue, bilaterally at the level of LI, using the 
same procedure as Giamberardino et al, (2005). The results showed that in both 
groups pain thresholds were significantly lower on the affected side (P<0.001). 
However the poor methodological detail, the lack of clear data analysis, the lack of a 
control group, the small sample used and the lack of blinding and randomization 
means that these findings again are difficult to rely upon.
Vecchiet et al, (1990) also measured pain thresholds to mechanical pressure, 
bilaterally, at the level o f LI with an electric myometer with a probe of 25mm 
diameter in the same group of 9 patients. The probe was applied to the cutaneous 
surface overlying the muscle ‘half way between the anguloscapular and posterior 
axillary lines and the exerted force was gradually increased in increments of 0.1 ‘k g f 
every second (though it is not clear what kgf is). The definition of the pressure pain 
threshold used was the point at which the patient defined the pressure applied as, 
‘tenderness’. The results showed that pressure thresholds were lower on the affected 
sides of both groups when compared to the unaffected side (P<0.03 for group 1 and 
P<0.02 for group 2). As with electrical stimulation these results could have been 
further strengthened by the use of a control group and blinding of the researcher to 
the subject group.
As with the study by Giamberardino et al, (2005), ultrasound was also used to 
determine muscle thinning and subcutaneous thickening in patients with painful 
(n=3) and non-painful (n=3) renal disease, however the number o f subjects in this 
part of the study was inexplicably reduced from 9 to 6, and unfortunately again, no 
control group was used. The method used was the same as used by Giamberardino et 
al, (2005), but again reliability was not tested or discussed. From this small 
experiment the results showed a mean decrease in muscle thickness of the affected 
side in both groups (mean difference = 2.0mm) and a mean increase of subcutaneous 
thickness (mean difference = 3.33mm for group 1, and 3.66mm for group 2). Further
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statistical analysis had not been evaluated and without normative data the clinical 
significance of these findings is again difficult to interpret.
2.2.2 Trophic Changes in Musculoskeletal Pathology
Two studies have investigated trophic changes in musculoskeletal pathology, one in 
osteoarthritis of the knee joint and the other in lumbar back pain and radiculopathy.
Osteoarthritis
Galletti et al, (1990) investigated trophic changes in 6 subjects with osteoarthritis o f 
the knee in a small non-blinded, non-randomized, non-controlled study. 
Unfortunately both the method and the results are very poorly described in this paper 
such that clear conclusions about trophic changes are difficult to draw. The 
methodology outlines that vasomotor changes were investigated using the 
dermograph machine along with skin observation and digital compression (fovea 
sign) for subcutaneous oedema. Subcutaneous changes were also evaluated 
quantitatively with a technique which entailed injecting the knee joint to measure its 
capacity, though as with the other sections o f the study, the procedure was not 
adequately described. No other trophic change studies have used this technique, and 
there have been no studies demonstrating its reliability or validity as a method to 
determine subcutaneous oedema. Subcutaneous and muscle tissue thickness also 
appear to have been measured by ultrasound, but the methodology does not detail 
this procedure. Overall the poor methodology and poor detailing of the results 
prevents thorough evaluation of the study findings.
Low Back Pain and Radiculopathy
In a prospective randomised controlled trial, Gunn and Milbrandt (1978) also 
investigated a series of skin and muscle changes in 2 groups o f patients, the first with 
primary back pain (30 patients) and the second with radicular (specifically sciatic) 
referred pain (30 patients), compared with a control group of 60 patients. The 
patients in the study were randomly selected from those attending an outpatient 
rehabilitation clinic (though the description of randomization is not described).
There was no blinding of the researcher to the subject groups identified in the 
methodology. As with many of the other studies described, a variety o f tests to 
examine trophic changes were conducted which included:
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a) Digital compression of motor points (in 2 muscles per segment from L2-S2)
b) Qualitative analysis of subcutaneous tissue by use of skin rolling (which entailed a 
piece of skin, approximately 5cm in diameter, being gently squeezed between the 
thumb and index finger, and judged for its ‘peau d ’orange appearance' and the 
resistance to ‘normal’ skin folding and inelasticity)
c) The matchstick test to determine subcutaneous oedema which entailed a blunt 
instrument (akin to a matchstick) being pushed firmly against the skin to make a 
compression indentation in the skin at the level of each lumbar nerve root 
(bilaterally) and in each lower limb segment. Following the compression, the 
indentation created was observed and its recovery to normal or the residual 
persistence o f compression in the skin was noted. No time period for measuring 
compression was given and no explanation of the criteria that had been used to grade 
skin recovery was reported
d) Palpation of muscle spasm assessed subjectively and scored on a 0-2 scale for 
level of firmness. (The criteria used for a positive test was a subjective description 
o f the firmness and shape of the muscle, with a ‘palpably firmer’ muscle and a 
muscle with an ‘easily discemable shape and size’ constituting a positive finding).
The results o f the experiment revealed that the trophic changes investigated occurred 
more frequently in patients with sciatic referred pain than in those subjects with low 
back pain alone or the control group, see table 1 below.
Table 1: Showing the frequency of trophic changes in each group (Gunn and 
Milbrant 1978)
Control
Group
Sciatic Referred 
Pain Group
Back Pain 
Group
Tender motor points 1.6% 100% 0%
Subcutaneous oedema 0% 20% 0%
Palpable muscle spasm 0% 63.3% 20%
Subcutaneous tissue changes 28.3% 76.6% 53%
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These results, though interesting, must be interpreted with great caution as the tests 
used lacked standardisation and validity. The results were also reported descriptively 
with no statistical analysis (possibly due to the age o f the study), and as such 
conclusions regarding the significance of the results are difficult to draw. As with 
other studies, reliability analysis o f tests used was not performed.
Summary
In summary the studies reviewed show that several trophic changes have been 
investigated which have included vasomotor changes such as plasma extravasation or 
subcutaneous oedema, and sensory changes such as responses to pressure or electric 
stimulation. The only motor change that has been investigated is palpable muscle 
spasm, and other motor symptoms which may represent changes in motor function, 
such as changes in muscle power, strength or electrical activity have not been 
discussed in the literature.
Overall the quality of the studies reviewed was poor with all scoring 0/5 on the 
JADAD quality scale, except the study by Gunn and Milbrandt (1978) which scores 
1/5 (see tables 2 and 3 at the end of this chapter page....). However studies in the 
musculoskeletal field particularly [both Gunn and Milbrandt (1978) and Galletti et al, 
1990)] also have significant methodological limitations such as the lack of 
standardized and valid measurement techniques. Studies in the visceral field have 
generally used more standardised techniques but even Wesselmann and Lai (1997) 
and Giamberardino et al, (2005) have used methods for which reliability has not been 
demonstrated. Overall the quality of the studies suggests that the results cannot be 
relied upon, and thus it is not clear whether trophic changes exist at all.
2.3 Trophic Changes as Diagnostic Indicators
It has been claimed by many authors that trophic changes are useful as indicators of 
pathology as they are thought to be found in the tissues to which pathological or 
painful structures refer pain (Giamberardino et al, 2005; Gebhart 2000; Cervero 
1995; Vecchiet et al, 1990; Galletti et al, 1990; Procacci et al, 1986; Gunn and 
Milbrandt 1978). Though all the researchers investigating trophic changes have 
suggested that they could be useful as diagnostic indicators of visceral or 
neuromusculoskeletal pathology, none of the studies whether old or recent, have
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conducted sensitivity or specificity analysis, and thus as yet, their use as diagnostic 
indicators is unknown. If trophic changes were shown to be sensitive indicators of 
pathology they could be very useful in clinical practice to supplement the clinical 
assessment and diagnosis process. It is thus important that tests used in sensitivity 
studies are suitable for use in clinical practice otherwise such tests are of limited 
value.
2.4 Mechanism of Trophic Changes
The studies discussed in section 2.2 have suggested several links between trophic 
changes and specific pathologies, as well as hypothesizing about the underlying 
mechanisms which exist. Wesselmann and Lai (1997) suggested a link between 
inflammation and the development of trophic changes following their work in uterine 
inflammation. Giamberardino et al, (2005) also noted that there was a significant 
difference in sensory and vasomotor trophic changes in those with a high number of 
painful gall bladder attacks, irrespective of gall bladder dysfunction, suggesting a 
link between trophic changes and pain rather than inflammation. The mechanisms 
underpinning these changes have rarely been investigated in specific trophic change 
studies, and thus the wider literature was drawn upon. The next section will discuss 
possible mechanisms thought to underpin trophic changes based on evidence from 
the wider literature under the heading of each trophic change.
2.4.1 Mechanism of Vasomotor Trophic Changes
O f all the vasomotor changes investigated, plasma extravasation has been studied 
most widely. Plasma extravasation has long been associated with inflammation and 
the triple response, typically injury results in an inflammatory process which is 
characterized by local vasodilation and extravasation of plasma into intercellular 
spaces. Plasma extravasation has also been associated with neurogenic inflammation 
(White and Helme 1985; Levine et al, 1985a).
The mechanism underpinning plasma extravasation has been identified as being 
mediated by a neural pathway following experimental research showing a correlation 
between plasma extravasation and electrical nerve stimulation (Brodin et al, 1981; 
White and Helme 1985). In a controlled animal study, White and Helme (1985) 
demonstrated that experimentally induced antidromic stimulation of the C fibres of
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the rat sciatic nerve resulted in neurogenic inflammation, characterised by local 
vasodilation and plasma extrasvasation. Further studies also showed that Substance 
P appeared to be the main chemical mediator o f neurogenic inflammation (along 
with calcitonin gene related peptide-CGRP) (McDonald et al, 1996, Rossi and 
Johansson, 1998). On release, these chemicals act on local blood vessels, increasing 
blood flow and vascular permeability, thus contributing to the development of 
oedema and plasma extravasation (Basbaum and Jessell, 2000; Daeman et al, 1998, 
McDonald et al, 1996).
Levine et al, (1986) found that all categories of nerve fibres were involved in the 
development of plasma extravasation not just C fibres. Levine et al, (1986) 
investigated experimentally induced arthritis in rats measuring both plasma 
extravasation and joint arthritic changes. In this study, 76 rat paws were used (actual 
number o f rats not given), compared with 60 control paws, and given an injection of 
adjuvant (mycobacterium) into the knee joint. Prior to the injection the animals were 
divided into several groups and underwent a variety o f procedures to attenuate the 
resulting experimental arthritis to determine which mechanism contributed most to 
these changes. The procedures included; administration of the neurotoxin capsaicin 
to neonatal rats (which destroys the dorsal root ganglion and thus eliminates the 
central and peripheral branches of the primary afferent nerves) (Gamse et al, 1981), 
sympathectomy with guanethidine or reserpine (destroys sympathetic fibres), and 
surgical deafferentation of the hind limb (which destroys central afferents but leaves 
the peripheral branches intact).
Following the interventions, rats in the experimental groups were examined and 
compared to a control group for signs of tenderness, experimental arthritis (x-ray 
used) and plasma extravasation/oedema (by measuring the amount of swelling 
produced with callipers). X-ray for arthritic changes was interpreted using a blinded 
examiner, and a grading system on a 0-3 scale o f severity. No evidence of reliability 
analysis or interpretation criteria was discussed and therefore the results must be 
interpreted with this in mind. The results of the study showed that there was no 
single class o f nerve fibre responsible for neurogenic inflammation in experimental 
arthritis, with large and small diameter afferents, sympathetic efferents and central 
spinal circuits all contributing to joint inflammation and plasma extravasation in rats.
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Sympathectomy with guanethidine or reserpine was shown to be the most profound 
way of attenuating signs of experimental arthritis and plasma extravasation, and 
therefore the authors suggested that the sympathetic nervous system is a significant 
mediator in the development of plasma extravasation. (However it must be 
acknowledged that these changes are primarily related to experimental arthritis, and 
though this may be relevant for the present research study, it may not be relevant for 
all trophic change plasma extravasation such as that from visceral pathologies).
One study has also investigated the underlying mechanism of vasomotor changes 
including plasma extravasation and axon flare in human subjects with a past history 
of complex regional pain syndrome (CRPS). In a controlled study, Leis et al, (2004) 
investigated whether electrical stimulation of C fibres resulted in plasma 
extravasation and circulatory change on the unaffected side of 12 patients (9 upper 
and 3 lower limbs used) in comparison to 12 control group subjects. Following the 
intervention, researchers found that there was an increase in the flare response 
(vasodilation) in the affected and unaffected limb (detected by laser Doppler 
flowmetry) suggesting that the mechanism underpinning vasomotor changes, even in 
the contra-lateral limb may be connected with C fibre stimulation. However though 
there was an increase in blood flow, plasma extravasation (measured by blue dye and 
photometric analysis) was only found in the affected (not unaffected) limb, which led 
to conclusions that in pathology such as complex regional pain syndrome, plasma 
extravasation (but not axon flare) is mediated by a local neurogenic mechanism. 
Interestingly these findings are somewhat contradicted by previous work of Levine et 
al, (1985c). In this study the researchers demonstrated a central mechanism for 
spatially remote plasma extravastion following an experiment in which electrical 
stimulation of rat cutaneous afferents increased vascular permeability in the contra­
lateral limb. Though Leis et al, (2004) had found only local mechanisms important 
in mediation o f plasma extravasation, this work thus suggests that central or spinal 
mechanisms may also contribute.
In a recent review article, Levine et al, (2006) also identified that several factors may 
influence the control of the inflammatory and plasma extravasation response, which 
may influence the existence of trophic changes in different populations. For example
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it has also been shown that stress and pain have a negative feedback effect on the 
ongoing inflammatory and plasma extravasation response (Khasar et al, 2005), and 
that co-existing inflammation in another part of the hind paw has a negative feedback 
effect on plasma extravasation (Green et al, 1995), [again dependent on the 
sympathetic terminals (Green et al, 1997)]. These findings suggest that populations 
with different types o f inflammatory or painful pathologies may have different levels 
of vasomotor changes. Green et al, (2005) also identified differences in plasma 
extravasation in male and female rats suggesting that trophic changes may vary 
depending on the gender of the test groups.
2.4.2 Mechanism of Sensory Trophic Changes
As described in section 2.1, mechanical hyperalgesia is another symptom which may 
be categorized as a trophic change. Hyperalgesia to mechanical stimuli has been 
reported to accompany many conditions such as fibromyalgia (Staud et al, 2001), 
visceral inflammatory conditions (Frokjaer et al, 2005) complex regional pain 
syndrome (Leis et al, 2004) and osteoarthritis (Bajaj et al, 2001). It is reported to 
have primary and secondary components, with primary hyperalgesia defined as that 
which occurs at the site of tissue damage, while secondary hyperalgesia is that which 
occurs in the uninjured skin surrounding the injury (Lewis 1942). The mechanisms 
for the development of primary and secondary hyperalgesia are different. Primary 
hyperalgesia is thought to be due to a peripheral neural mechanism, where as 
secondary hyperalgesia is thought to be underpinned by a central neural mechanism- 
central sensitisation (Meyer et al, 1994), and it has been suggested that central 
sensitisation may be the mechanism which underpins hyperalgesic trophic changes 
(Giamberardino et al, 2005).
Central sensitisation is the term used to describe an increase in the excitability of 
spinal cord neurones (Woolf 1994), which has been shown experimentally by 
activating cutaneous and muscular, C fibre afferents (Wall and W oolf 1984; Woolf 
and Wall 1986). These afferents produce slow excitatory synaptic potentials which 
summate resulting in the unmasking of a receptor (called the NMDA receptor) which 
is normally blocked until certain conditions are satisfied (Dickenson 1999). The 
NMDA receptor is unique in that opening is dependent on membrane voltage as well 
as the chemical transmitter (Mayer et al, 1984), and once these conditions are met,
26
the NMDA receptor is exposed and can combine with transmitter substances which 
results in the dorsal horn cells becoming hypersensitive to incoming noxious 
information, (Dickenson and Sullivan, 1987; Dickenson and Besson, 1997; 
Dickinson et al 1991; Woolf and Thompson, 1991; Price et al, 1994). The 
unmasking of the NMDA receptor allows the post-synaptic cell to produce much 
larger responses to a normal input, and to express previously weak or relatively 
ineffective inputs. This can result in altered, prolonged, enhanced (hyperalgesia) or 
referred pain symptoms (W oolf 1994; Johnson, 1997).
The mechanism for the development of central sensitisation has been studied by 
several authors in both animals and in humans. W oolf and Thomson (1991) 
investigated the mechanism by blocking the NMDA receptor in the dorsal horn with 
NMDA antagonists in in-vitro preparations. Others investigated the mechanism by 
blocking the temporal summation evoked by electrical stimulation of C fibre 
afferents in in-vivo preparations without reducing the responses of other fibres such 
as A-delta fibres (Dickenson and Sullivan 1987; Dickenson et al, 1991).
Price et al, (1994), investigated the mechanism by studying the effects of NMDA 
blockade in human subjects exposed to experimentally induced pain which had been 
mediated by C fibre stimulation (commonly called second pain to distinguish its 
mechanism from that of fast immediate pain thought to be initiated by A-delta 
activation) (Price et al, 1977). Price et al, (1994) conducted a small controlled 
experiment using 6 normal male volunteer subjects who were exposed to noxious 
heat and noxious electrical stimuli, however 2 of the subjects were authors of the 
paper which may suggest some bias. The NMDA receptor antagonist was given 
orally in several different dose forms (including a control dose) and on several 
different days in what is described but not evaluated as ‘quasi-random’ order. 3 
doses were given on a double blind basis but whether the authors were also given 
double blind doses is not accounted for. The visual analogue scale was used as an 
outcome measure and it was shown that the NMDA receptor antagonist reduced 
temporal summation of electrically and thermally evoked second pain in a dose 
dependent manner in humans. The effects of the NMDA receptor were selective as 
the experiment showed that the A-delta fibres responsible for ‘first pain’ had not 
been affected (which mirrors previous animal study findings).
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Central sensitization has not yet been demonstrated to exist for long periods of time 
in experimental conditions, and therefore it is thought that other mechanisms may 
also influence the development of hyperalgesia such as A-beta fibre sprouting 
(Nakatsuka et al, 1999). In a controlled animal study (number of rats not given), 
inflammation in the hind paw was experimentally created with injection of 
mycobacterium, which produced a persistent peripheral inflammation characterised 
by oedema (measured by callipers), and mechanical hyperalgesia measured by von 
Frey hairs. Following inflammation, the dorsal root ganglia o f the experimental 
group were isolated and compared to the dorsal root ganglia in control rats. On 
analysis, a change in synaptic responses was observed with a decrease in A-delta 
monosynaptic inputs into the substantia gelatinosa, and an increase in A-beta 
monosynaptic afferents (33%). Conclusions from this work suggest that re­
organisation of the dorsal horn may also be a factor in the development of 
hyperalgesia, particularly in cases of inflammatory pathology.
2.4.3 Mechanism of Motor Trophic Changes
Motor trophic changes are the least well studied o f the 3 sub-groups of trophic 
changes discussed, and mechanisms underpinning muscle spasm or motor changes 
are not well understood. Following their research Gunn and Milbrandt (1978) 
hypothesised that denervation supersensitivity could explain the existence of motor 
and vasomotor trophic changes such as muscle spasm or subcutaneous oedema. 
Denervation supersensitivity is characterised by the denervated structure becoming 
more sensitive to circulating chemicals such as acetylecholine or noradrenalin. 
Increased sensitivity has been shown to occur due to an increase in receptor sites in 
the denervated structure (Axelsson and Thelseff 1959). This physiological 
phenomenon has been observed in many animal studies, in both smooth and skeletal 
muscle, with receptor sites which are normally only found at the end plate, spreading 
across whole the muscle fibre, leading to an increase in the muscular response 
(Axelsson and Thelseff 1959; McConnell and Simpson 1976; Merlie et al, 1984; 
Cangiano 1985).
Flowever despite numerous animal studies demonstrating denervation 
supersensitivity over the last 50 years, few human studies were found which have
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measured the number of receptors following denervation. One small, non 
randomized and non blinded study measured the number o f alpha receptors in 8 
patients with sympathetic denervation (compared to 5 control), and found an increase 
in the number of receptors (Davies et al, 1982). However unfortunately the findings 
were not correlated to trophic change symptoms such as blood flow or spasm and 
therefore this theory remains unsubstantiated as a mechanism for the development of 
motor or vasomotor trophic changes. No other mechanism for the development of 
muscle spasm or motor trophic changes has been proposed.
One further complication with regards to motor trophic changes is that reviews of the 
wider literature have shown that questions have been raised about whether muscle 
spasm exists at all. In 1966, De Vries suggested that pain led to the development of 
muscle spasm, and outlined a phenomenon called the pain-spasm-pain cycle. Since 
then several authors have tried to investigate the existence o f muscle spasm primarily 
through surface and needle electromyography, however conclusions as to whether to, 
or how to, measure muscle spasm, are still somewhat unclear. The difficulties with 
the measurement of motor trophic changes and muscle spasm will be discussed 
further in the method section 3.4.3 page...
2.5 Reversal or Attenuation of Trophic Changes
The review so far has focussed on the identification of the existence of trophic 
changes (for use as indicators of pathology) rather than on the effects of interventions 
or treatments on their existence. One study, (which has only been considered in 
abstract form as it is published in Italian), has however investigated the effects of 
topically applied heparin-glucuronylglucosaminoglycane on trophic changes, in a 
double blind placebo-controlled trial in 20 female subjects with painful, osteoarthritis 
of the knee (n=10 in control group, n=10 in experimental group) (Dragani et al,
1992). (Heparin-glucuronylglucosaminoglycane is a chondroprotective drug with 
anti-inflammatory properties used in osteroarthritis). Subcutaneous and muscular 
pain thresholds were assessed (by electrical stimulation), along with subcutaneous 
and muscle tissue thickness (assessed by ultrasound). Measurements were taken at 
baseline then one, two, and three weeks after treatment with the drug or placebo. 
Subcutaneous and muscular pain thresholds were shown to be increased as early as 1 
week after treatment, subcutaneous tissue thickness was significantly decreased two
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weeks after treatment and in the same period a statistically significant increase in the 
thickness of the vastus medialis muscle was also noted. No such changes occurred in 
the placebo-controlled group. In the abstract the authors suggest that the peripheral 
control of inflammation and the resultant reduction in pain may be a possible 
underpinning mechanism for these changes.
The evidence of Wesselmann and Lai (1997) linking vasomotor trophic changes and 
inflammation, and the study by Nakatsuka et al, (1999) which linked persistent 
dorsal horn changes following inflammatory pain and hyperalgesia, both show a link 
between trophic changes and inflammation. It is possible that a reduction in 
inflammation may well lead to reduced trophic changes, however apart from Dragani 
et al, (1992) no studies have investigated the effects o f commonly used anti­
inflammatory agents such as cortico-steroids or non steroidal anti-inflammatory 
drugs on trophic changes in humans. It is possible that trophic changes could not 
only provide diagnostic information but could also be useful indicators of 
inflammatory recovery. Therefore as will be identified below the second part of this 
experiment aims to investigate whether trophic changes are affected by 
administration o f corticosteroid.
2.6 Summary and Aim of the Research
In summary, this chapter has reviewed the previous studies which pertain to the 
measurement o f trophic changes, with studies in visceral, musculoskeletal and 
radicular pathology. In the main it has been shown that the quality of the studies, 
particularly in the musculoskeletal field, is poor. Despite claims that trophic changes 
are sensitive indicators o f pathology, it has been shown that none of the studies have 
investigated sensitivity or specificity and thus these claims cannot be substantiated. 
Furthermore links to pathology are also unclear, experimental evidence has shown a 
link between vasomotor trophic changes and inflammation, which has been shown to 
be underpinned by all classes o f afferent neurones particularly sympathetic, whereas 
general pain research has shown a link between hyperalgesia, central sensitisation, 
increased C fibre activity and dorsal horn changes. Finally it has been shown that 
investigations into treatment effects on trophic changes have so far been very limited. 
The reduction of hyperalgesia and subcutaneous thickness has been shown with 
topical application of heparin-glucuronylglucosaminoglycane, however no other
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studies into the effects o f pain relieving or anti-inflammatory medication have been 
conducted.
These findings have demonstrated that evidence of the existence and sensitivity of 
trophic changes in the neuromusculoskeletal field is lacking. If these changes are to 
be useful as indicators of pathology, pain or inflammation, they need to be able to be 
detected in clinical practice so that if they are shown to be sensitive they can be used 
widely. The lack o f investigation into the effects of treatments such as anti­
inflammatory or analgesic medicines on trophic changes demonstrates another area 
worthy o f investigation as these findings may provide information regarding 
recovery.
As the literature has shown that there has been little investigation in the 
neuromusculoskeletal field, this research will focus on changes in subjects with 
upper limb and cervical pathology as these have not been investigated in any trophic 
change study. As cervical radiculopathy and frozen shoulder are conditions which 
have been noted as being significantly painful (Codman 1934; Middleditch and 
Jarman 1984; Bunker 1998), relatively common (Wainner and Gill 2000; Ostor et al, 
2005), and difficult to diagnose (Date and Gray 1996), these conditions will be 
selected for study. Both C5 cervical radiculopathy and frozen shoulder refer into the 
C5 segment, and therefore subjects with these two conditions will be investigated. 
The changes to be investigated will be those that have been identified as part of the 
family of trophic changes discussed at the beginning of this chapter and thus include 
one change from each vasomotor, sensory and motor sub group.
The study aims to:
1. Determine whether clinical tests o f vasomotor, sensory and motor trophic changes 
were sensitive indicators of frozen shoulder and cervical radicular pathology.
2. Determine the effects of cortico-steroid injection on trophic changes in frozen 
shoulder.
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Research Questions
1. Are clinical measures of trophic changes sensitive indicators of frozen shoulder or 
cervical sensory radiculopathy?
2. Can cortico-steroid shoulder joint injection reduce trophic changes in frozen 
shoulder detected by clinical tests?
Research Hypotheses
1 .There will be a significant difference between trophic changes detected in frozen 
shoulder and cervical radiculopathy when compared to a control group (vasomotor 
changes and sensory changes will be increased on the affected side, motor changes 
will be reduced on the affected side).
2.Trophic changes will be sensitive indicators o f frozen shoulder pathology but not 
cervical radicular pathology.
3. There will be a significant difference in trophic changes in subjects with frozen 
shoulder following an injection of cortico-steroid into the shoulder joint (vasomotor 
and sensory changes will be reduced, and motor changes will be increased on the 
affected side following injection).
2.7 Intended Outcomes of the Research
It is hoped that the information gained from this study will add to the body of 
knowledge concerning the existence of trophic changes in neuromusculoskeletal 
pathology and whether these changes are affected by the use o f anti-inflammatory 
medication. This information may add to the knowledge concerning the types of 
pathology in which trophic changes are found.
It is hoped that the study will provide information concerning whether trophic 
changes can be detected by simple tests which can be used widely in clinical practice 
and whether these changes are sensitive indicators of the pathology investigated such 
that they may assist with clinical diagnosis of shoulder and cervical dysfunction.
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Table 2: The Quality of Studies which have Investigated Trophic Changes. The 
JADAD quality measurement tool has been used.
Study Quality Measurement with 
JADAD Scale
Score
Giamberardino et al, (2005) Non randomized, Non blinded 
No explanation of dropouts
0/5
Wesselmann and Lai (1997) Not applicable Not applicable
Vecchiet et al, (1990) Non randomized, Non Blinded 
No explanation of drop outs
0/5
Galletti et al, (1990) Non randomized, Non Blinded 
No explanation of drop outs
0/5
Gunn and Milbrandt (1978) Randomized (procedure not 
described), Non blinded 
No explanation of dropouts
1/5
Table 3: The Descriptors used in the JADAD Scale for Quality Assessment
1. Was the study randomized Yes=l No= 0
2. Was randomization described and appropriate Yes=l No= 0
3. Was the study double blinded Yes=l No= 0
4. Was Blinding described and appropriate Yes=l No= 0
5. Was there a description of drop-outs? Yes=l No= 0
Maximum total score 5
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CHAPTER 3
METHOD 
Introduction
This was a non-randomized controlled study which took place in Eastern 
Birmingham Primary Care Trust (with pilot work conducted in South Birmingham 
and Bristol South and West Primary Care Trusts). It was carried out in 2 
experiments, the first aimed to investigate the diagnostic sensitivity o f trophic 
changes which can be used in clinical practice, in cervical sensory radiculopathy and 
frozen shoulder. The second study aimed to investigate the effect of corticosteroid 
on trophic changes in subjects with frozen shoulder, 4 weeks following intra-articular 
shouder injection.
The method chapter is organised such that the context and background to the 
research is outlined in section 3.1. The participants used in study 1, the inclusion and 
exclusion criteria and the ethics procedure are then described in section 3.2. Section 
3.3 covers an in depth analysis and justification of the alternative methods for each of 
the 3 outcomes to be investigated. Section 3.4 describes the equipment selected for 
this study which includes the modified matchstick test, pressure pain rating with the 
numerical rating scale and surface electromyography. These methods were used to 
investigate vasomotor, sensory and motor trophic changes respectively. The pilot 
study work which led to the development of these methods and the reliability 
analysis o f each outcome is also described. The procedure for the main experiment 
is detailed in section 3.5, the methods for each outcome are identical to those used in 
the reliability testing and are included in this section only, to avoid repetition. The 
subject recruitment, ethics process and study procedure for study 2 is described in 
section 3.6 and the data and statistical analysis for both studies is discussed in section 
3.7.
3.1 The Research Context
As discussed in the literature review, trophic changes have been investigated in 
visceral, osteoarthritic and radicular pathology, however the existence and sensitivity 
of trophic changes in the upper limb and cervical spine has not been studied. The 
shoulder and cervical spine were chosen for investigation as it has been identified
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that these conditions can be difficult to differentially diagnose (Date and Gray 1996). 
The incidence of cervical radiculopathy and frozen shoulder have been estimated to 
be around 3.3 cases (Wainner and Gill 2000) and 1.425 cases (Ostor et al, 2005) per 
1000 respectively which is much lower than back pain (estimated at 44 cases per 
1000, Kopec et al, 2004) but of greater incidence than diseases such as rheumatoid 
arthritis (estimated at 0.31 cases per 1000, Hanova et al, 2006). Thus though the 
incidence of cervical radiculopathy and frozen shoulder is not as great as other 
musculoskeletal pathologies, these conditions still make up a significant number of 
conditions seen by musculoskeletal specialists and investigation in this area is 
therefore justified.
If trophic changes were found to be sensitive indicators of pathology it is important 
they could be used widely in clinical practice. Therefore the methods employed in 
this study needed to be portable, simple to use requiring minimal training, and where 
possible be of low cost so that they could be taken up easily by clinicians. The 
literature review demonstrated that previous studies which have investigated trophic 
changes have measured them in the area to which pain refers. Therefore in this study 
it was deemed appropriate to measure trophic changes in the area to which frozen 
shoulder and cervical radiculopathy refer pain. C5 sensory radiculopathy and frozen 
shoulder both refer pain into the C5 dermatome, therefore this area was selected in 
which to measure trophic changes (thus only C5 cervical radiculopathy patients were 
used).
The second part o f the study aimed to investigate whether trophic changes were 
affected by cortico-steroid injection. The experimental evidence suggests that the 
existence of trophic changes is related to inflammation and it is possible that if 
trophic changes are shown to be altered by steroid medication, they could not only 
provide diagnostic information, but could also be useful indicators of recovery. As 
frozen shoulder is a condition of inflammatory aetiology often treated by cortico­
steroid injection this group was chosen for this study.
3.2 Research Participants, Recruitment, Consent and Ethics
Ethical approval was granted by the West Birmingham Local Research Ethics 
Committee (pilot study Ethics approval granted by the South West Local Research
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Ethics Committee). All subjects gave informed consent (see information leaflets and 
the consent form used in appendix Al pg...). The research participants were drawn 
from General Practice referrals to a musculoskeletal Physiotherapy Department. For 
experiment 1, subjects were recruited into 2 experimental groups, group 1 -the 
cervical radiculopathy group, and group 2 -the frozen shoulder group. Control 
subjects were recruited and matched for age and gender. For experiment 2 subjects 
were recruited from the pool of participants in experiment 1 with frozen shoulder and 
compared to the control group. Recruitment of subjects was not randomized because 
difficulties in obtaining the required sample size prevented this method (though it is 
acknowledged that this would have been superior). However subjects were recruited 
consecutively from referrals from a wide range of GP practices (90 in total) without 
prior selection. Prior to the main experiment, reliability of the equipment for each 
outcome used was tested with 20 subjects from the control group.
3.2.1 Sample Size and Power Analysis
Previous unpublished data (from PhD pilot work 2005) had shown that the scores for 
most outcomes and groups tested were not of a normal distribution. The power and 
sample size calculations for this study were based on the assumption that non 
parametric statistics would be used in the analysis because the data was unlikely to 
be normally distributed (given previous pilot results), and the majority of data was of 
an ordinal nature. The sample size calculations for this study were carried out by the 
Heart of England NHS Trust Statistician, R Holder. They were specifically tailored 
for a non parametric analysis using NQUERY (version 5.0), a specialist software for 
sample size calculations. The method used was based on that recommended by 
Noether (1987) for common non-parametric sample size determination.
For experiment 1 the calculations showed that using a 5% significance test with an 
effect size o f 1 (exact calculation 0.93), a sample size of 31 would be sufficiently 
large to ensure that there was a 90% probability (power) o f rejecting a false null 
hypothesis, (i.e. that there would be an 90% probability of correctly detecting those 
cases whose result is significant).
For experiment 2, the calculations showed that using a 5% significance test with an 
effect size o f 2, a sample size of 17 would be sufficiently large to ensure that there
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was an 80% probability of rejecting a false null hypothesis (using a Wilcoxon Test 
for analysis).
Based on these findings a total 93 subjects were recruited into study 1, n=30 for the 
control group, n=31 for the cervical radiculopathy group and n=32 for the frozen 
shoulder group. Subjects were also matched to the control group for age and gender, 
and the number of subjects per gender per group is shown in the table 4. In 
experiment 2, 17 frozen shoulder subjects were recruited for injection and compared 
to 30 control subjects. 10 further subjects with frozen shoulder who declined 
injection were recruited as an extra control (named the non injection group). The 
number of male and female subjects in the injection and non injection groups in 
experiment 2 is also shown in table 4. 5 subjects dropped out of experiment 2. 
Specific reasons were not given.
Table 4: Gender of Subjects Recruited for Each Group
Group Male Female Total
Control Group 13 17 30
Cervical Radiculopathy Group 14 17 31
Frozen Shoulder Group 14 18 32
Injection Group 7 10 17
Non Injection Group 5 5 10
3.2.2 Inclusion Criteria
A summary o f the inclusion/exclusion criteria for all groups can be seen in table 6.
a) Cervical Radiculopathy Group
The inclusion criteria for the cervical radiculopathy group had to be developed for 
this study because no definitive diagnostic criteria exists (Carette and Fehlings 2005; 
Wainner and Gill 2000; Radhakrishnan et al, 1994; Dillin et al, 1986). Experimental 
studies which document the clinical signs o f radiculopathy are scarce, and evidence 
tends to be drawn from clinical experience or personal opinion (Radhakrishnan et al, 
1994).
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Therefore a pilot study was used to determine the most common symptoms in 
patients referred with C5 cervical sensory radiculopathy. Physiotherapy referrals 
from 10 general practitioners were examined over a 3 month period. The first 10 
referrals with diagnostic labels of ‘C5 cervical nerve compression’, ‘C5 trapped 
nerve’, fcC5 brachial nerve root irritation’, ‘C5 cervical radiculopathy’, C5 cervical 
spondylosis, were identified consecutively from the referral centre and marked so 
that extra details could be obtained during their first assessment. Each patient was 
given an appointment with the study operator, and the presence o f common signs and 
symptoms which have been associated with cervical radiculopathy (listed in table 5) 
were documented. It is important to note that these signs and symptoms have not 
been determined experimentally, rather over time, these signs and symptoms have 
been suggested to be indicative of cervical radiculopathy and have become accepted 
by clinicians.
Table 5: Common Signs and Symptoms Associated with Cervical Radiculopathy
Common Signs and Symptoms of Cervical 
Radiculopathy
Reference
1 Pain referral pattern in the affected 
dermatome/myotome
(Kellgren 1939; 
Cyriax 1983)
2 Pain elicited by cervical movements of side 
flexion or rotation
(Wainner et al, 2003)
3 Sensory changes of parasthesia and 
anaesthesia
(Hardy and Plank 
1982)
4 Reflex loss and myotome weakness (Dyck and Thomas 
1982)
5 Presence o f pain on palpation o f the affected 
spinal segment
(Maitland 1986)
The results from the pilot study were compiled and tabulated (see appendix A l, 
tables A 1.1-A 1.3 page.). In summary, all subjects had pain in the C5 dermatome, 5 
out o f 10 had cervical pain on rotation towards the affected side, and two had pain 
when side flexing away, consistent with Wainner et al, (2003). None of the patients 
examined in the pilot study had reflex loss or discemable myotome weakness, and 1
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subject had parasthesia and anaesthesia. Only 1 subject had pain on palpation of the 
C5 cervical segment alone, (9 subjects had pain on palpation of all segments).
The inclusion criteria was therefore based on the findings of the pilot study and is 
shown below, subjects had to have all 3 symptoms.
• Pain initiated or aggravated by cervical rotation towards and/or cervical side 
flexion away from the affected side (Wainner et al, 2003)
• Referred pain into the C5 dermatome, which had originated in the cervical 
spine (Kellgren 1939; Cyriax 1983)
• Pain as a consequence of palpation of the cervical spine inter-vertebral joints 
(Maitland 1986).
As the other sensory and motor signs were not commonly found they were not 
included in the inclusion criteria.
b) Frozen Shoulder Group
Frozen shoulder is another condition for which a clear diagnostic criteria does not 
exist. Frozen shoulder is a term which describes a shoulder condition of unknown 
aetiology, which is characterized by a number o f shoulder symptoms first described 
by Codman (1934). These descriptions arose from clinical observation and they have 
not been demonstrated experimentally, nor has sensitivity analysis been conducted. 
However they are widely used in physiotherapeutic and orthopaedic medicine and 
they form the basis of descriptions used by other authors such as (Cyriax 1983). The 
inclusion criteria for frozen shoulder (based on Codman 1934) is listed below, 
subjects should have all of the signs and symptoms:
• Gradual onset o f ‘trying’ pain
• Shoulder pain referring into the deltoid with little local tenderness
• Inability to sleep on the affected side
• Painful and incomplete elevation and external rotation
• Passive and active restriction of movement
A more recent addition to the criteria came from Cyriax (1983) (again from clinical 
observation rather than experimental work). Cyriax (1983) stated that movement
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restriction in a capsular pattern also exists in frozen shoulder not just loss of lateral 
rotation and elevation. However as there have been questions raised over the 
reliability of the capsular pattern (Rundquist et al, 2003), this has not been included 
in the criteria. In the original frozen shoulder criteria (Codman 1934), atrophy of the 
spinati was also suggested to be a sign o f frozen shoulder. However as Bunker 
(1998) has questioned the existence of this sign in frozen shoulder it has also been 
omitted from the criteria.
Control Group
Subjects in the control group were matched in age and gender to the experimental 
groups (see further rationale for matching in section 3.4.2 pg..).
3.2.3 Exclusion Criteria for all Groups
• Subjects with a history systemic joint disease (such as rheumatoid arthritis or 
ankylosing spondylitis) were excluded because systemic arthritic conditions 
may cause swelling which could lead to false positive results in the modified 
matchstick test.
• Subjects with recent traumatic neck injury or shoulder injury (particularly 
soft tissue trauma) in the last 12 months were excluded because resultant 
local swelling could lead to an increased number o f false positive results in 
the modified matchstick test.
• Subjects with co-existing shoulder or upper limb pathology were excluded 
from the cervical and control groups and subjects with co-existing cervical 
pathology were excluded from the shoulder and control groups.
• For all groups, subjects were excluded if they were under 18 years old or 
pregnant (due to consent issues and systemic changes respectively).
• Subjects who demonstrated significant red flag pathology (such as 
unexplained weight loss over 5% of body weight, signs of systemic infection,
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drop attacks, speech and swallowing problems, significant dizzyness) were 
excluded from all groups and managed appropriately.
Table 6: Inclusion and Exclusion Criteria for All Groups
This table summarises the inclusion and exclusion criteria for all groups
Inclusion Criteria Exclusion Criteria All 
Groups
Cervical 1 .Pain initiated or aggravated by cervical 1.Subjects with a
Radicular rotation towards and/or cervical side flexion history systemic joint
Group away from the affected side disease
2.Referred pain into the C5 dermatome. 2.Subjects with recent
which had originated in the cervical spine traumatic neck injury or 
shoulder injury in the
3.Pain as a consequence o f palpation o f the 
cervical spine inter-vertebral joints
last 12 months
Frozen 1.Gradual onset o f ‘trying’ pain 3.Subjects with co­
Shoulder existing shoulder or
Group 2.Shoulder pain referring into the deltoid 
with little local tenderness
upper limb pathology 
4.Subjects with co­
3.Inability to sleep on the affected side 
4.Painful and incomplete elevation and
existing cervical 
pathology
external rotation 5.For all groups, 
subjects were excluded
5.Passive and active restriction of if they were under 18
movement years old or pregnant
Control Subjects with no shoulder or cervical
Group pathology were recruited into the control 6.Subjects who
group matched in age and gender to the demonstrated
experimental groups significant red flag 
pathology
41
3.3 Consideration of Alternative Methodology
As 3 separate outcomes were measured in this study (i.e. vasomotor, sensory and 
motor) this section is split into 3 parts which identify the alternative methodologies 
which were considered for use in this study.
3.3.1 Methods to Investigate Vasomotor Changes
As identified in the literature review, in previous trophic change studies, vasomotor 
changes were investigated indirectly by measurement of the flare and plasma 
extravasation response, as well as by measuring subcutaneous oedema and alterations 
of skin texture. Despite these tests being cited in several papers, reliability has not 
been investigated. The use of plasma extravasation methodology may also require 
that clinicians gain advanced skills for administration of blue dye which reduces the 
suitability of this method for widespread use in clinical practice. The invasiveness of 
dye injection and the associated risks such as bleeding or infection, also raise the risk 
of this method beyond its diagnostic benefit in musculoskeletal practice and therefore 
it was considered unsuitable for this study.
In the general literature a variety of methods and equipment have been used to 
determine vasomotor changes, however, a gold standard test for use in clinical 
conditions has not been identified so far. One of the most reliable and valid methods 
that has been used to quantitatively measure vasomotor function is laser Doppler 
flowmetry (LDF) (Caspary et al, 1996; Bircher et al, 1993; Nilsson et al, 1980). The 
underlying principle is based on the change in frequency which occurs in light beams 
when they are directed on to moving red blood cells in comparison to the unshifted 
frequency which occurs when the beam is directed towards static tissue. Nilsson et 
al, (1980) investigated the validity of LDF by measuring its performance using a 
fluid model in which the red cell velocity, concentration and oxygen content could be 
controlled. They found that the signal output measured, increased proportionally to 
the red cell volume and flow velocity indicating its validity to measure change in 
blood flow. Reliability measurements of LDF were not clearly reported in the study 
and therefore assurance regarding reliability of this tool could not be made from this 
early work. Consistent blood flow changes in response to temperature changes were 
reported, but it is unclear from the method or results, how many measurements were 
taken during this part of the study.
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On further analysis of the literature, very few clinical studies have tested the 
reliability of laser Doppler flow, though a variety have used LDF to measure blood 
flow. For example Sumikura et al, (2003) used LDF to measure the correlation 
between neurogenic inflammation and hyperalgesia, Karason and Drysdale (2003) 
used LDF in a small non-randomized study measuring dermatomal blood flow 
changes before and after high velocity, low amplitude, spinal manipulation, and 
Lofgren et al, (2001) measured lumbar skin blood flow changes before and after 
posterior or anterior cervical spinal decompression. However none of these studies 
reported reliability testing of the equipment used.
Though less specific to the research o f this study, short term reliability analysis was 
reported by Iwao et al, (1993) who investigated LDF of gastric mucosal blood flow 
in 32 subjects (12 control, 20 with liver cirrhosis). Four measurements were 
recorded in 10 minute intervals by 2 blinded observers. The intra-class correlation 
coefficient was used to assess observer agreement showing intra and inter-observer 
agreement to be 0.87 and 0.86 respectively, demonstrating a high to excellent 
reliability for the 2 examiners (using the Landis and Koch (1977) scale, see appendix 
A1.3 pg...)» The coefficient of variation was more variable with average and 
maximum values o f 12% and 35% respectively for examiner 1, with similar levels 
being reported for the second examiner. Despite the relatively high levels of 
reliability, the authors concluded that ‘although the reproducibility of laser Doppler 
flowmetry was clinically acceptable, it appeared to be a subjective experimental 
measurement tool in this area’ and thus it seems that reliability in each specific 
situation should be tested. Unfortunately though LDF is one of the only tools 
reviewed for which reliability and validity has been shown, the use of this tool was 
prohibited in this study by the Electrical Service Department o f the NHS Trust 
involved, on the grounds of ‘concerns over equipment maintenance, insurance and 
safety’ and therefore other methods had to be considered.
Thermography is also a method of indirectly measuring vasomotor changes by the 
temperature response that results from changes in blood flow. In a literature review, 
Plaugher (1992), concluded that generally studies investigating the reliability of 
thermography were scarce and often poorly conducted, which questions the
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appropriateness o f thermography as an outcome measure for this study. However a 
more recent study by Owens et al, (2004) assessed the intra and inter-observer 
reliability of thermography with 2 examiners in 30 asymptomatic subjects in a non­
randomized and non-blinded study, and showed high levels of reliability for 
thermography. Unfortunately the lack of blinding reduces the value of these results, 
and it appears that further reliability analysis would be useful before conclusions 
regarding reliability can be firmly made. The Electrical Service Department was also 
contacted with regards to the use of thermography for a reliability pilot study, 
however again this was refused on the grounds of maintenance, insurance and safety.
The fact that both LDF and thermography were prohibited in this study, and the 
finding that other methods previously used lacked validity, reliability, and suitability 
for use in a clinical study, demonstrated that there was a need for the development of 
a new method of measuring vasomotor changes, which was suitable for clinical 
practice. Most previously used tests of vasomotor activity such as skin observation 
were difficult to modify in conjunction with valid or reliable measurement tools and 
were thus rejected. However the matchstick test used by Gunn and Milbrandt (1978) 
to measure subcutaneous oedema (indirectly through the delivery of compression to 
the skin) was considered highly suitable to adaptation so that it could be used in 
combination with algometry or similar valid pressure measurement. This ‘modified 
matchstick test’ was considered ideal for this study because it had the advantage of 
portability and simplicity, and could be conducted easily in a variety of clinical 
environments with little training required for use or interpretation. The test 
development and reliability analysis can be seen in the next section 3.4, page...
3.3.2 Methods to Investigate Sensory Trophic Changes
As identified in Chapter 2, the only sensory trophic change to be investigated in 
studies specifically investigating trophic changes was hyperalgesia. The 
hyperalgesic response to manual palpation (Giamberardino et al, 2005; Gunn and 
Milbrandt, 1978), and to electrical stimulation (Giamberardino et al, 2005) have both 
been reported. Unfortunately, as with many of the vasomotor tests used, manual 
palpation lacks standardization and known force measurement. On searching the 
general literature to determine reliable and valid measures o f hyperalgesia testing, 
pressure algometry and electric stimulation were the most commonly cited methods,
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and both are said to be valid (Fischer 1987a; Sang et al, 2003). However it must be 
noted that the measurement of hyperalgesia with either electrical stimulation or 
pressure algometry is dependent on the patient’s subjective experience which is in 
turn influenced by the cultural, cognitive and emotional perspectives of those being 
tested (Kosek et al, 1993; Janal et al, 1991).
Electrical stimulation has been shown to be a reliable tool to measure pain threshold, 
though many less reliability studies have been conducted than in pressure algometry. 
Sang et al, (2003) investigated the stability and reliability o f electrical stimulation 
using monopolar, constant-current rectangular pulses, delivered on 3 separate 
occasions to 5 equi-spaced sites on the anterior aspect of the left forearm along a 
transverse line, 5cm distal to the cubital crease. The results showed that no 
significant differences were recorded on repeated tests or at different sites 
demonstrating reliability of repeated measures and consistency in pain reporting at 
different sites. These results show that electrical stimulation could be used to 
determine hyperalgesia in a clinical setting such as in this study, however it has the 
disadvantage that it requires more staff training than pressure algometry, as well as 
the fact that some of the associated equipment (such as oscilloscope to determine 
wave shape) is also less portable and thus less satisfactory for clinical studies. 
Pressure algometry has also been shown to be a reliable and valid tool to measure 
pressure pain (Fischer 1987a). As it is more simple to use and more portable than 
electrical stimulation it was considered more suitable for the clinical environment. It 
was thus selected to determine sensory trophic changes in this study. The equipment 
used and the reliability analysis are discussed in section 3.4.2 pg. ..
3.3.3 Methods to Investigate Motor Trophic Changes
The literature review identified that muscle spasm has been the only motor trophic 
change previously investigated (Gunn and Milbrandt 1978; Giamberardino et al, 
2005), however there is no consensus regarding the measurement of muscle spasm 
and even its existence is questioned. One in-depth review paper was found which 
attempted to define muscle spasm, highlighting the ambiguities between the terms 
muscle tension, muscle spasm and muscle tone (Simons and Mense 1998). The 
authors suggested that muscle spasm was defined as the ‘electromyographic activity 
of the muscle that is not under voluntary control and not dependent on posture’,
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though they did not substantiate this definition with experimental evidence of 
electromyography (EMG) readings in subjects with muscle spasm. Thus according 
to this definition, muscle spasm is represented by the level o f electromyographic 
activity within the muscle that is not under voluntary control, and as such ''could be 
measured by the level o f EMG activity’ implying that EMG should be measured at 
rest and without postural effort.
However earlier work by Jones et al, (1987) contradicts the suggestions made by 
Simons and Mense (1998). In their small, non-randomized, non-blinded, non­
normalized experimental study (n=7), EMG and muscle stiffness o f a painful bicep 
muscle were investigated following repeated eccentric contraction. They found that 
after the intervention, significant muscle stiffness occurred, but EMG levels 
measured at rest were electrically silent, suggesting that muscle spasm did not 
correlate with electrical activity at rest.
When reviewing the methods of other studies which have claimed to measure muscle 
spasm, both EMG at rest and during activity has been measured. For example 
Larsson et al, (1999) investigated ‘muscle spasm’ in a non- randomized, non-blinded, 
non-normalized study in 76 subjects, with surface EMG from the trapezius muscle, 
measured at rest and during muscle contraction following incrementally increasing 
static loads. In this study, measurements at rest did not reveal electrical silence as in 
the study by Jones et al, (1987), but they did appear to be very low, with no 
significant differences reported until higher levels of contraction were employed 
(exact values at rest not reported). In contrast using a randomized, non-normalized, 
double blind crossover design study (n=20) to determine the effects of muscle 
relaxants on muscle spasm, Bajaj et al, (2003) measured electrical activity with 
surface EMG during a maximum voluntary contraction rather than measuring 
electrical activity at rest. Though the results of this study are not applicable to this 
work, the method employed suggests that measuring changes in electrical activity 
during muscle contraction is more appropriate than measuring electrical activity at 
rest. Thus in summary, studies aiming to measure muscle spasm have either found 
no significant muscle spasm when measuring electrical activity at rest (Larsson et al, 
1999; Jones et al, 1987) or have not measured muscle activity at rest (Bajaj et al, 
2003).
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The disparity between these experimental findings, and the theoretical definition of 
Simons and Mense (1998), suggests that use o f the term muscle spasm is misleading, 
and it was considered more appropriate to use the term which represents the outcome 
being measured (i.e. electrical activity) rather than the term muscle spasm. Changes 
in electrical activity are representative of changes in the recruitment of motor units, 
which is one way of measuring changes in motor activity, (though the cause of 
changes in electrical activity cannot be clearly attributed and may include influence 
from peripheral, spinal or cerebral areas). Other methods o f measuring motor 
activity may include strength evaluation with the oxford scale, dynamometry, or 
timed measurement of functional tasks. The use of the oxford scale was considered 
unsuitable for this study due to subjectivity and lack of validity. Unfortunately 
shoulder dynamometry equipment tends to be large to ensure thoracic stabilisation, 
and was therefore was not suitable for use in a clinical outpatient setting because of 
its lack o f portability, (the cost was also prohibitive for this study). Small hand held 
dynamometers are portable and low cost, however their use around the shoulder was 
considered inappropriate, due to the lack of stabilisation. Time measured functional 
tasks were also considered inappropriate for this study as many patients would have 
significant pain on movement and therefore a test of relatively short duration was 
considered particularly important. Overall the measurement of electrical activity 
during muscular contraction was considered to be the most appropriate measure of 
motor trophic changes.
On searching the literature electromyography appears to be the primary measure of 
muscular electrical activity and has been considered a valid measure of electrical 
activity for many years, other methods of measuring electrical activity include motor 
evoked potentials, H Reflexes and F Waves. Motor evoked potentials (MEPs) and H 
reflexes are primarily measures of the velocity of motor nerve conduction rather than 
motor unit recruitment. MEPs are responses that can be recorded from the muscle 
after electrical or magnetic stimulation of the central nervous system or the proximal 
nerve root, and they primarily provide information about the conduction velocity of 
central or spinal motor pathways (Pascual-Leone et al, 2002; Wilboum and Aminoff 
1998). MEPs require a controlled environment as well as operator skill and 
specialist interpretation, such that MEPs were considered unsuitable for use as a 
clinical test to be employed in musculoskeletal clinics. The El reflex is also a
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measure o f nerve conduction and is indicated primarily in investigations o f the spinal 
reflex loop (Clark et al, 2006; Fisher 2002; Pierrot-Deseilligny and Mazenet 2000; 
Burke et al, 1985; Troni et al 1983). Interestingly, although H reflexes are stable in 
adulthood, they are only commonly present in the soleus and forearm flexor muscles 
(Fisher 2002; Clark et al, 2006). Therefore the FI reflex was not appropriate for this 
experiment where the aim of the investigation was to study the muscles innervated 
by the 5th cervical roots. Experimental evidence from Shimsheimer et al, (1985) 
adds weight to the statement made by Fisher (2002), where H reflexes were 
measured in 32 patients with C5 -  C8 nerve root injury, confirmed by myelography, 
and compared to 143 control subjects in a non-randomised and non-blinded study. 
The findings showed that in those patients with C5 or C8 nerve root injury, the H 
reflex could not be detected, where as in C6 and C7 root injury, H reflexes were 
shown, though the lack of blinding prejudices these results.
The F wave like EMG, is a measure of the motor neurone output from the spinal 
cord, however it is only representative of a small number of motor units, usually less 
than 5% of the associated compound motor unit action potential (Yates and Brown, 
1979). The F wave is produced when a supramaximal stimulus, delivered to the 
peripheral motor nerve produces an antidromic volley o f nerve impulses which travel 
back to the spinal motomeurones and induce re-excitation o f the axon causing a late 
excitation of the muscle known as an F wave (Pascual-Leone et al, 2002). These late 
responses have small amplitudes as they are produced by discharge from a small 
number of motor units, and are considered to be inherently variable (Fisher et al, 
1994; Mesrati and Vecchierini 2004) (it is recommended that for accurate 
measurement, a series of 20 or more stimuli are required to yield approximately 16- 
20 F waves) (Fisher et al, 1994) which means they are less useful for clinical 
practice. Though F waves may yield some information regarding the electrical signal 
in the muscle, they do not appear to have been used for the assessment of 
background electrical activity in kinesiological studies or studies of muscle spasm. 
Thus in summary surface EMG was considered to be the most suitable method for 
this study. The equipment used and reliability analysis is described in section 3.4.3, 
page....
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3.4 Equipment
As the aim of this study was to determine the diagnostic sensitivity o f trophic 
changes with methods that could be used in clinical practice, all instrumentation 
needed to be appropriate for the clinical environment. The equipment used and the 
reliability studies for each outcome measure are described below.
3.4.1 Modified Matchstick Test
The matchstick test used by Gunn and Milbrandt (1978) is a test o f subcutaneous 
oedema and entails delivering a compression force to the skin using a blunt 
instrument (similar to, but not defined as a matchstick). The presence o f residual 
compression indicates the presence of subcutaneous oedema. As discussed in the 
literature review, previously compression force had been delivered manually and 
therefore test modification was required to develop a valid test where a known force 
could be applied. To deliver the compression force to the skin a cylindrical plastic 
tube similar to an acupuncture guiding tube, was selected because it was blunt, could 
provide the appropriate spread of force without discomfort and was plastic such that 
it could be cleaned between patients. The tube was inflexible, 50mm in length, 
3.5mm in diameter, with a rim of 1mm thickness (see figure 1). Other similar 
instruments such as plastic syringes may also be suitable. As pressure algometry has 
been shown to be a valid and reliable tool in both clinical and laboratory 
environments (Fischer 1987a), this was considered most suitable for delivering a 
standard compression force, via the plastic tube to the skin rather than using manual 
pressure. A non digital FDN 10 algometer (Wagner Instruments USA) was used.
Figure 1: Cylindrical Compression Tube for Modified Matchstick Test
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A pilot study was conducted to determine:
a) the appropriate pressure required to create compression in the subcutaneous tissues
b) the length of time required to determine the presence of abnormal residual 
compression and,
c) the criteria for interpretation.
The pilot study (see Appendix A1.2 pg.. for details) was undertaken on the 
assumption that the force had to be great enough to create skin compression which 
lasted for a few minutes, but not too great such that the force may damage the skin or 
take too long to return to normal levels, (as increased time for test completion would 
increase the risk of the test loosing its usefulness in busy clinical practice). Force 
less than that required for pressure pain measurement was used because pressure was 
exerted through a small, stiff tube which increases the pressure load onto the skin. 
Therefore in the pilot study, forces of 2.5, 5, 7.5 and ION were trialed (see results in 
appendix A1.2 , table A1.4, page..). The results showed that with a plastic tube of 
50mm length and 3.5mm diameter, a force of 5N was most suitable (forces of 2.5N 
did not leave a consistent compression and those over 5N were sometimes painful). 
The results o f the pilot study monitoring the length of time for residual skin 
compression to return to normal showed that skin was recovered at 5 minutes in 
control subjects (See results in Appendix A1.2, table A1.5 page...). However as this 
was extended beyond 5 minutes in 2 subjects it was considered appropriate to 
monitor the skin at both 5 and 10 minutes.
Gunn and Milbrandt (1978) had not identified the criteria by which skin would be 
judged to be ‘recovered’ or still ‘indented’. As no previous criteria had been 
proposed, an arbitary scoring system was developed based on ease of identification 
o f the remaining indentation. If the indentation was fully visible it was given a 
compression score of 1, and if the indentation was not visible at all it was given a 
score of 0. Where there was partial recovery, a score of 1 was given if the 
indentation ring was 75% or more complete, partial recovery of less than 75% was 
scored as 0.
Reliability of the Modified Matchstick Test and Measurement Error
To determine the level of intra-observer reliability of the modified matchstick test, 20
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control subjects were consecutively selected. On first assessment subjects were 
screened using the inclusion and exclusion criteria described above for the control 
group, and informed consent was gained. Subjects were tested initially and then the 
test was repeated 4 weeks later. The procedure was the same as that used in the main 
study described in section 3.5 page....
The difference between the number of compression scores for each side (left side 
subtracted from right side) was calculated for each test. The reliability of the data 
was analysed by comparing the level of agreement between the difference scores 
obtained at the 2 time periods. As the data was o f an ordinal nature, the kappa 
coefficient was used (Sim and Wright 2000). A kappa value o f 0.79 was obtained for 
repeated testing at 5 minutes, and 0.61 at 10 minutes. The standards set by Landis 
and Koch (1977) indicate that results between 0.61 and 0.80 are considered to have 
‘substantial’ levels of agreement which provides support for the use of the test in this 
study. Thus the results showed that in conjunction with a valid tool such as pressure 
algometry, the modified matchstick test was shown to be reliable.
According to De Mast and Van Wieringen (2004) ‘measurement precision is 
interpreted as reliability by the social sciences and can be viewed as the degree of 
variation, or equivalently, as the correlation among multiple measurements’. For 
ordinal measurements quantification of measurement error or precision can be found 
by the correlation between pairs of readings with the kappa correlation coefficient 
(Bland 2000; De Mast and Van Wieringen 2004). For interval or ratio data 
measurement error may be determined by the intraclass correlation coefficient or by 
the within subjects standard deviation as seen later in section 3.4.3 (Bland 2000).
For the modified matchstick test the kappa coefficient has been calculated as 
discussed above, which has shown that there was less measurement error at 5 
minutes than at 10 minutes.
3.4.2 Pressure Pain Rating
Sensory changes were determined with a non digital FDN 50 Algometer (Wagner 
Instruments USA) used in conjunction with the numerical rating scale. On analysis 
of the variety of methods to measure pressure pain the use of a pain rating scale was 
considered most appropriate for this study. Pressure pain thresholds were discounted
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as they can sometimes be difficult to determine due to difficulties finding the exact 
point when a subject first perceives a stimulus (Fischer 1986). They can also take 
time to complete, and require a significant concentration from the patient, usually 
away from other stimulus.
On analysis of pain scales previously used Gagliese et al, (2005) compared the 
validity of a variety of pain scales including the visual analogue scale (VAS), the 
numerical rating scale (NRS), and the verbal descriptor scale (VDS) (which utilizes 
descriptions of pain e.g. 5=worst pain, 4=severe pain etc) in 504 post-operative 
patients spanning a wide range of adult ages. The numerical rating scale had the 
lowest error rates and patients reported that this scale most accurately represented 
their pain. The VAS on the other hand was associated with higher error rates, high 
non score data, low face validity, and was not recommended for use in the elderly 
post operative patient. In a study of 175 patients (age range 25-94), Herr et al,
(2004) found that all pain scales (VAS, VRS, VDS) were valid measures of pain, but 
also identified that again patients found that the VRS represented their pain intensity 
most accurately, followed by the verbal descriptor scale.
In support of these findings Ferraz et al, (1990) evaluated the reliability of the VAS, 
NRS and VRS in illiterate and literate patients with chronic rheumatoid arthritis 
(total n=91; illiterate=25, literate=66). Scales were presented to patients in random 
order, twice, before consultation with their doctor. The intra-class correlation 
coefficient was calculated for literate and illiterate patients (see table 7 below) 
showing that the numerical rating scale achieved the highest reliability rating in both 
groups o f patients.
Table 7: Intra-class Correlation Coefficients for Illiterate and Literate Patients 
using a variety of Pain Rating Scales
Pain Scale ICC for Literate Patients ICC for Illiterate Patients
VAS 0.937 0.712
NRS 0.963 0.947
VRS 0.901 0.820
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In contrast reliability of the VAS and the NRS was investigated by Good et al,
(2001) in a randomized controlled trial, with results showing that the VAS was 
slightly more reliable than the NRS. Patients were tested on 2 separate days after 
surgery (day 1 and 2), and on each of these days, pain assessment was measured 
twice, with a 15 minute space between each measurement to test reliability. The 
results showed that the VAS scored slightly higher than the NRS (ICC ranged from 
0.73-0.82 for VAS and 0.72-0.78 for NRS). In summary the numerical rating scale 
consistently appears to be more valid and reliable than the other scales, with the 
exception of the work by Good et al, (2001) where the VAS achieves slightly higher 
reliability scores. The numerical rating scale also has the advantage of being ideal 
for patients to rate pain when their upper limbs are under test and thus was 
considered ideal to use in combination with pressure algometry.
The level o f force used was determined by the consideration of work in previous 
studies. Mean pressure pain measurements (in asymptomatic subjects) of 36.25N 
have previously been recorded by Chesterton et al, (2003) using an algometer of 
1.1 cm tip diameter. However because the algometer used in this study was non 
digital, it was not possible to accurately and consistently measure a value o f 36.25N 
without prolonging the pressure pain experience. This finding, in conjunction with 
the fact that the algometer tip used in this study was slightly smaller at 1cm diameter, 
resulted in a slightly reduced compression force to 35N.
Short term reliability of pressure has been demonstrated by Chesterton et al, (2003) 
where repeated pressure pain measurement was performed in a large, blinded study 
using 2 groups, 1 group of 240 subjects, and 1 group of 30 subjects who were 
randomly selected from the large group of 240 subjects. In the first study using the 
larger group, the initial measurement was taken and then repeated 15-20 minutes 
later, where as in the second study, initial algometer readings were taken from 14 
points over the body, then repeated 6 times at 10 minute intervals. The results for 
both studies showed that there were no significant differences between the initial 
readings and those taken on repeated sessions (study 1 P=0.892; study 2 P= 0.280).
However Kosek et al, (1993) found longer term reliability (up to 13 weeks) to be 
poor, in their study of 12 healthy female volunteers where they measured pressure
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pain thresholds in over 30 points, in different tissues, in randomized order (mainly 
over the trunk). Three sets of measurements were taken, the first and second 
measurements were separated by 1 week, and then the third set was taken 10-13 
weeks later. Their results also showed that there was no significant difference 
between measurements taken initially and at week 1, but 10-13 weeks later, the mean 
thresholds were significantly different to the previous 2 readings (P<0.001), 
indicating that in the long term, pain thresholds were not reliable. However the study 
also showed that in normal subjects, there were no significant differences between 
each side tested, or between the dominant and non-dominant side demonstrating that 
differences which occur between sides, are likely to be associated with hyperalgesic 
responses.
Mid term reliability was investigated by Ohrbach and Gale (1989) in a small, non­
randomized study of 10 asymptomatic subjects (5 male, 5 female). Measurements at 
2 sites over the temporalis and masseter muscles were taken at weekly intervals over 
4 weeks and then at a fifth session at 8 weeks. The subjects and the sites tested were 
randomized at each session. Over both sites there were no significant differences 
found over the first 4 weeks or at the fifth session at week 8 (P=0.828). Intra-class 
correlations varied for all comparisons made but overall the results showed that there 
was good to high reliability for most measurements. Thus for pressure algometry 
short and medium term reliability has been shown (up to 8 weeks) but questions still 
remain over long term reliability. These findings support the methodology in this 
study for trophic changes to be measured at week 4. Reliability analysis for this 
study was conducted as previous studies had not been conducted in the deltoid area 
(see below).
Despite reliability it has been suggested that both age (Lee et al, 1994) and gender 
(Chesterton et al, 2003) may confound the results of pressure pain threshold analysis. 
In their study conclusions, Lee et al, (1994) proposed that age affects the pressure 
pain threshold, however the statistical analysis in the paper does not support this 
suggestion. In the study discussed above Chesterton et al, (2003) found that pressure 
pain thresholds at the dorsal interossei were significantly lower in females than males 
(P<0.0005), though many other studies have failed to show significant gender 
differences (Lee et al 1994; Fillingim et al 1999; Berkley 1997). It was suggested by
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Chesterton et al, (2003), that many of the studies which have not shown a gender 
difference, have not used a large enough sample size, (though Lee et al, (1994), used 
a sample of 207, but no power analysis was given). The finding o f a significant 
gender difference when analyzing pressure pain in the hand, (Chesterton et al, 2003) 
must also be considered in light of the trend which has shown a greater divergence 
between male and female pressure pain in highly innervated areas, (like the hand) 
(Fillingim et al, 1999). Therefore gender differences may be relevant for some 
studies but not necessarily for this study which aimed to investigate hyperalgesia at 
the shoulder. However at present, with no clear consensus on age and gender 
differences, it was considered appropriate to match experimental and control groups 
on age and gender, thus reducing the effect of these confounding variables.
Reliability of Pressure Pain Rating and Measurement Error
The reliability o f pressure algometry (FDN 50-Wagner Instruments USA) in 
combination with the numerical rating scale has not been conducted in the deltoid 
area and therefore reliability testing was conducted. Reliability was tested before 
proceeding with the main study with 20 control subjects, at baseline and 4 weeks 
later (see section 3.5 for a detailed description of procedure).
The difference of the NRS scores for each side were calculated initially and then for 
the values taken 4 weeks later. The level of agreement between these 2 sets of NRS 
scores was analyzed using the Kappa coefficient as recommended for ordinal and 
nominal data (Sim and Wright 2000), as the ratio properties of these subjective pain 
rating scales have been questioned. The results of analysis showed that there was an 
agreement of 0.93, which corresponds to almost perfect agreement on the Landis and 
Koch (1977) scale (see appendix A 1.3 page.... for scale). The high level of 
reliability o f this valid measurement tool justifies the use of this method as a measure 
of hyperalgesia (and thus sensory trophic changes) in this study.
The same considerations concerning measurement error discussed in 3.4.1 applied to 
pressure pain rating. Quantification of measurement error and reliability was 
conducted with the kappa coefficient for ordinal data. The results above suggest that 
the pressure pain rating was the most reliable outcome used in this study with the 
least measurement error.
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3.4.3 Surface Electromyography
Surface electromyography (sEMG) is widely used in the musculoskeletal field for the 
measurement of electrical activity (Gaudreault et al, 2005; Pascual-Leone et al, 2002; 
Soderberg and Cook 1984). The electrical signal emanating from the muscle, 
detected by electromyography, ‘is the algebraic summation of motor unit action 
potentials (MUAPs) from all active motor units, within the pick up area of the 
electrode’ (Basmajian and Deluca 1987). Several factors can affect the data obtained 
such as the type of electrode used (surface or needle), the type o f contraction (static 
or dynamic), the normalization procedure, the placement of the electrode and its 
location in reference to the motor point, and the recording, analysis and interpretation 
of the signal (Basmajian and Deluca 1987). Surface EMG is indicated when 
detection o f electrical activity from numerous individual motor units is required and 
for relatively simple assessments of the electrical activity in superficial muscles. 
Needle EMG is indicated for analysis of a single, or a small number of motor units 
and is comparatively invasive requiring some technical skill (Kamen 2004). The 
advantages of easy use, low training requirements, low cost, portability, non-invasive 
technique, and the indications for use in superficial muscle analysis demonstrate that 
surface EMG was more appropriate than needle EMG for this study. The two 
important parameters of the EMG signal are the frequency and the amplitude 
(Kamen 2004; Basmajian and Deluca 1987). The signal amplitude reflects muscle 
activation (both the number of active motor units activated and the firing rate) (Beck 
et al, 2005; Kamen 2004). The frequency o f the signal is also affected by these 
factors, but primarily reflects the average conduction fibre velocity (Basmajian and 
Deluca 1987; Lindstrom and Magnusson 1977). Although both the amplitude and 
the frequency of the signal may reveal information about the electrical activity of the 
muscle in both experimental groups, the aim of this study was primarily to determine 
data pertaining to the level of muscle activation (number of motor units) rather than 
conduction fibre velocity, and therefore measurement o f the amplitude parameter 
was considered the most suitable.
The Pathway MR 20 dual channel, portable surface EMG unit (Prometheus Group, 
USA), (Range = 1-800 microvolt, Band pass filter = 20-500 Hz) was used with self 
adhesive, surface active electrodes with a built in signal amplifier (high input 
resistance o f 10 gigohms to reduce the sensitivity to noise ratio) (Turker 1993;
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Basmajian and Deluca 1987). Each electrode had 3 contact surfaces, 2 for signal 
detection (inter-electrode distance 10mm), and the third being a built in reference 
electrode. As the machine was a portable battery operated unit, no earth electrode 
was required. The Pathway MR 20 automatically samples and analyses the 
amplitude signal. This built in feature was considered important for this study to 
facilitate its use in clinical practice.
The amplitude signal was automatically sampled at a rate o f 1250Hz (as required by 
Niquist equation) (twice the upper limit of the band pass filter). Once sampled, the 
signal amplitude was automatically analyzed by root mean square (RMS). A root 
mean square circuit is reported to provide a nearly instantaneous output of the power 
of the EMG signal and is considered to have a sounder mathematical basis than many 
other methods of processing (Soderberg and Cook, 1984; Basmajian and Deluca 
1987), however other techniques are still widely used. In line with the standards for 
electromyographic reporting (Merletti et al, 1999), and guidance from Soderberg and 
Knutson (2000), the root mean square should be reported for a particular time period, 
over which the RMS is calculated, (no minimum or maximum time periods are 
stipulated). On analysis of the literature many previous studies (e.g. Roe et al, 2006) 
have commonly used RMS amplitude values calculated for ‘epochs’ of 0.1s (100 
milliseconds). The MR 20 specification includes a built in the time period for RMS 
analysis o f 0.1 s.
On analysis o f the general kinesiological studies which have used surface EMG in 
the shoulder region, it appears that the reliability is variable and conclusions 
regarding the reliability o f specific techniques or test positions are difficult to draw 
because of the large amount of methodological variation pertaining to electrode 
placement, muscle tested, task investigated, data obtained and equipment used. As a 
general rule intra-day reliability has been shown to be more reliable than inter-day 
reliability, and experiments using isometric contractions are generally more reliable 
than isotonic contractions. As the aim of this study was to investigate trophic 
changes in the C5 dermatome, studies which have investigated the reliability of 
surface EMG around the shoulder, were used where possible from which to draw 
conclusions.
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Roe et al, (2006) examined the reliability of peak amplitude surface EMG (root mean 
square-rms) in 26 subjects with and without neck and shoulder pain (18 
asymptomatic, 8 with shoulder and neck pain), over a 3 year period. Subjects 
performed 3 maximal voluntary contractions (held for 4 seconds) and 1 sustained 
sub-maximal isometric contraction of the deltoid and trapezius muscles, with the 
shoulder joint positioned at 45 degrees of abduction to facilitate peak force 
generation. The subject group was not randomized but was drawn from a large 
working population with a variety of age ranges. (Initially 104 subjects were 
recruited but following criteria exclusions and dropouts, 26 remained). For maximal 
contractions of the deltoid muscle, the intra-class correlation coefficients for intra­
subject variability over 3 years ranged from 0.67-0.89 showing moderate to high 
reliability. Intra-subject variability over 1 day was much less, with intra-class 
correlation coefficients of 0.85-0.95 showing high levels of reliability. The 
coefficient of variation (CV) over 3 years for maximal contraction shoulder 
abduction was 1-37% and on repeated tests within the same day the CV was 1-34% 
showing similar values. The CV for sub-maximal contractions of shoulder abduction 
ranged from 2-65% showing more variation than the maximal voluntary contraction.
Other studies have reported less favourable reliability statistics, though direct 
comparisons are difficult as studies have used different parameters. For example in a 
study conducted by Minning et al, (2007) differences in shoulder muscle fatigue 
were investigated in the deltoid muscle (and other shoulder muscles), by surface 
EMG frequency analysis rather than amplitude analysis. 16 asymptomatic subjects 
performed an isometric contraction, whilst holding a weight of 60% of their MVC, at 
90 degrees o f shoulder elevation. The results demonstrated good intra-day test 
reliability (intra-class correlation ranged from 0.75-0.83), however inter-day test 
reliability ranged from very poor to good (0.03 - 0.76) depending on the muscle 
tested.
Nordander et al, (2004) investigated the reliability o f peak amplitude (rms) surface 
EMG from the infraspinatus muscle, and also found relatively poor reliability 
(though the study was very small). EMG analysis of specific work tasks was 
undertaken with normalization to maximum voluntary contraction, in 6 healthy 
female volunteers. Intra-class correlation coefficients were not calculated, but the
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between days and between subjects coefficient of variation was shown to be quite 
large at 15% and 57% respectively. In summary, the method and positions used in 
the study by Roe et al, (2006) demonstrated the most reliable short and long term 
values, and were thus adopted where possible for this study. As there were some 
variations, such as the equipment used, reliability testing was conducted.
Reliability of Surface EMG and Measurement Error
The procedure for reliability testing was the same as the procedure for the main 
experiment (see section 3.5 page., for further details). As with reliability testing for 
the other outcomes, 20 control subjects were consecutively selected from the 
physiotherapy referrals using the criteria as outlined in section 3.2. In brief, the root 
mean square peak amplitude signal was recorded from each deltoid muscle during 
the MVC. The difference between the MVC contraction for each side was calculated 
and then reliability analysis between baseline and measurement at 4 weeks was 
conducted. As the data was normally distributed (see appendix A l .5, figures A l . 1 
and A 1.2 page 113-114) and was of an interval/ratio nature, an intra-class correlation 
coefficient to determine level of agreement between the 2 time periods was 
calculated (Sim and Wright 2000). It has been recommended that the ICC used for 
analysis should reflect the situation in which future analysis is likely to take place 
(Sim and Wright 2000). Thus an ICC (2,1) model was used which identifies that 
raters would be assigned to subjects for re-measurement, rather than a different set of 
raters being used for each measurement which is most likely to reflect clinical usage. 
The MVC reliability demonstrated moderate to poor agreement with an ICC value of 
0.6. Though the level of reliability was moderate it was felt that this method would 
still be useful to give an indication of the existence o f motor trophic changes and 
their diagnostic sensitivity. However it was acknowledged that an ICC of 0.6 was on 
the lower limit of acceptable reliability and this is further considered in the 
Discussion chapter. A normalized EMG test as well as a maximum voluntary 
contraction had originally been conducted (see appendix A 1.4 page 110 for details on 
the uses of normalization and the procedure employed in this study). However the 
intra-class correlation coefficient of the normalized EMG values between the 2 test 
points was poor (ICC=0.25), and thus the normalized procedure was not considered 
to be reliable enough for use in the main study.
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The technical information for the Pathway MR 20 reports that it has an accuracy of 
2% +/- 2 microvolts (for values o f less than 500 mv), however measurement 
precision calculated specifically on the subjects in this study showed much less 
precision. As discussed previously measurement error can be calculated by 
correlation of two sets of measurement or by the within subjects standard deviation. 
As the EMG data was normally distributed and was interval in nature, the within 
subjects standard deviation was calculated (see table A1.7 appendix A1.6 page 115) 
and found to be 47.54mv. Following the British Standards Institution (1979) 
guidance, measurement precision may be quoted as beipg within 2 standard 
deviations, therefore for the peak amplitude measured with surface EMG during the 
maximum voluntary contraction, measurement precision was 95.08mv. As the mean 
of the first set of values for the control group was -30.9mv, this shows that surface 
EMG in this study lacks precision and appears to be related to large measurement 
error, thus the results must be interpreted with this in mind. As with other studies the 
between subject variance when quoted within 2 standard deviations was also shown 
to be large at 122.08mv.
3.5 Experimental Procedure -  Study 1
3.5.1 Modified Matchstick Test
Trophic changes were measured in the C5 dermatome for all outcomes as this is the 
site to which frozen shoulder and C5 radiculopathy refer pain (Kellgren 1939). 
Subjects were seated in a relaxed position with their hands resting on the mid thigh. 
Compression was delivered to the skin 1 cm above the deltoid tuberosity by placing 
the rim of the small hollow plastic guide tube (3.5mm diameter, 50mm in length, rim 
1mm thickness), against the skin horizontally, and then placing the rubber tipped 
ION algometer (Wagner Instruments USA) against the free end of the plastic tube. A 
force o f 5N was delivered in the horizontal plane from the algometer to the skin via 
the tube. This was repeated 5 times such that after the procedure 5 compression 
rings (of 1mm thickness) were evident on the skin, (see figure 2). The procedure was 
repeated on the opposite side, (both arms were tested but the order of testing for each 
arm was randomized). Following the compression on both sides, a stopwatch was 
started and the skin at each compression site was photographed at 5 and 10 minutes 
following the procedure post compression.
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Figure 2: Example of Skin Compression Following the Modified Matchstick
Test
Skin lesions of 5-10mm in diameter require photography of a focus distance of 
approximately 5cm (Medical Photography Guidelines, Bristol Royal Infirmary). 
Therefore the skin was photographed with a Nikon digital camera, (model coolpix 
880), 3.34 mega pixels at distance of 5cm from the compression site. Each 
photograph was assessed for clarity at the time of the experiment and then saved for 
interpretation and analysis. If the clarity was poor the photograph was repeated 
immediately. After the procedure the skin photographs were reviewed and the 
number o f residual compression scores remaining at the 5 and 10 minute 
measurement point were counted and recorded for each side. The data analysis 
section, 3.7 describes how this data was reduced and analysed.
3.5.2 Pressure Pain Rating
The area around the deltoid motor point was chosen as the site for hyperalgesia 
testing because the motor point was used as a site to determine hyperalgesia in the 
previous study by Gunn and Milbrandt (1978). Motor points have been suggested to 
be more hyperalgesic than other areas of the muscle, though no experimental data 
supports this suggestion.
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Subjects were seated in an upright position on an adjustable plinth, with hips and 
knees at 90 degrees and feet placed in neutral on the floor. The area of the skin at the 
motor point of the middle fibres the deltoid muscle was surface marked (the motor 
point is said to be found at the point between the lateral aspect of the acromion and 
the head of the humerus with the arm placed at 90 degrees o f abduction) (Forster and 
Palastanga 1985). The hyperalgesic response was then measured at this site by 
placing the algometer tip onto the skin surface, and then applying a constant force of 
35N.
Subjects were asked to rate the level of discomfort experienced during force delivery, 
using the numerical rating scale to determine the level of pain/discomfort 
experienced. Before the test, subjects were given an explanation of the numerical 
rating scale, to ensure they were familiar with the method of rating pain. Subjects 
were asked to verbally rate the level of their perceived pain intensity on a numerical 
scale from 0 to 10, with the zero representing one extreme (e.g. no pain) and the 10 
representing the other extreme (e.g. “ the worst pain possible”) as used by Randall et 
al, (2004).
3.5.3 Surface EMG 
Subject Position
Subjects were seated in an upright position on an adjustable plinth, with hips and 
knees at 90 degrees and feet placed in neutral on the floor as used by Roe et al, 
(2006). The shoulder under test was positioned at 45 degrees o f glenohumeral 
abduction in the scapula plane (elbow and wrist joint neutral). Other studies have 
used positions varying from 10 degrees (McLean 2005), 20 degrees (Brown et al, 
2007) and 90 degrees (Minning et al, 2007) of abduction. However the 45 degree 
mid position is highlighted by Kendall et al, (1983) as the position which promotes 
maximum force production and was thus considered ideal for testing the maximum 
voluntary contraction.
Electrode Placement
Prior to placing the electrodes, the skin was cleaned with a mediswab alcohol wipe to 
reduce skin impedance (Kamen 2004). It is recommended that the surface electrodes
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are placed away from the motor point of the muscle because this area produces the 
most variable EMG signal (Kamen 2004). As discussed earlier the motor point of 
the middle fibres of deltoid has been identified as the point between the lateral aspect 
of the acromion and the head of the humerus with the arm placed at 90 degrees of 
abduction (Forster and Palastanga 1985). The electrodes were therefore placed away 
from this point, midway, on a line between the deltoid tuberosity and the mid point 
of the lateral aspect of the acromion. They were placed in parallel with the muscle 
fibres to ensure a consistent signal, as it has been shown that when the electrode is 
not placed in parallel with the muscle fibre, the signal may be reduced by as much as 
50% (Kamen 2004).
Maximal Voluntary Contraction
Following positioning, subjects were asked to perform 3 static maximum voluntary 
contractions o f the deltoid muscle against a manual resistance delivered to the lower 
part of the humerus just above the elbow. Each deltoid was tested in random order.
A contraction time of 4 seconds and an inter-trial rest period of 2 minutes were used 
as in the study by Roe et al (2006), with verbal encouragement to facilitate the 
maximum voluntary contraction. No standard time length for holding the maximum 
voluntary contraction has been identified in the literature, however it is advised that 
the time period over which the contraction is held should not exceed the time that 
maximum effort can be exerted such that the muscle becomes fatigued (Soderberg 
and Knutson, 2000). The 4 second contraction time used was considered long 
enough to gain a MVC, but short enough to reduce the risk o f fatigue. Other studies 
have used contraction times from 400 milliseconds (Brown et al, 2007), to 1 second 
(Brindle et al, 2006). The peak amplitude during each maximum voluntary 
contraction was recorded with the Pathway MR20 portable surface EMG unit as 
outlined in section 3.4, and the root mean square was automatically calculated. The 
highest value o f 3 maximum voluntary contractions was used which is the procedure 
used in the study by Morris et al, (1998). Other studies have averaged the MVC 
results but as the aim was to gain the value for the maximum voluntary contraction, 
this method was deemed to be the most appropriate.
Prior to the procedure subjects were given the opportunity to practice before any data 
was collected. 3 practice sessions were carried out as it has been estimated that
63
without training, the MVC could be as much as 20-30 % less than that obtained after 
appropriate training (Merletti et al, 1999). Yang and Winter (1983) recommend that 
several repeated MVC contractions also improves the reliability of readings from 
maximal and sub-maximal contractions and those studies using 3 repeated MVC 
contractions have shown reliable results (Roe et al, 2006; McLean 2005). Other 
studies (Morris et al, 1998; Brindle et al, 2006) have used 1 or 2 repeated MVC 
contractions, but no reliability data was available from these studies to determine 
whether this method was also acceptable. Once the procedure had been completed 
the data was analysed as discussed in section 3.7.
3.6 Experiment 2
The aim o f experiment 2 was to determine whether cortico-steroid shoulder injection 
affected existing trophic changes in frozen shoulder.
3.6.1 Ethics, Consent and Research Participants
The same ethical and consent procedures applied for this part of the study. In 
experiment 2, subjects recruited from the frozen shoulder group were subject to 
further investigation (the same inclusion and exclusion criteria were used). From the 
32 subjects with frozen shoulder initially recruited in study 1,17 subjects (7 male, 10 
female) who consented to an injection o f corticosteroid were consecutively selected 
and matched to 30 control subjects (13 male and 17 female). Subjects who did not 
consent to an injection but who consented to take part in the study as a further 
control were also recruited and underwent the same procedure as the control (n=10).
3.6.2 Procedure Experiment 2
All subjects were exposed to the baseline measurements o f the modified matchstick 
test, pressure pain rating and surface EMG (rms) during maximum voluntary 
contraction as described above in the procedure for experiment 1. Following 
baseline measurements, subjects who had consented received an injection of 
corticosteroid (Kenalog-dose 30mg) using a posterior approach with an aseptic 
technique, into their affected shoulder joint, in line with the Association of Chartered 
Physiotherapists in Orthopaedic Medicine, Injection Therapy Guidelines. Each 
patient was positioned in long sitting and the posterior angle of the acromion was 
identified. The skin was marked, cleaned with a steret and allowed to dry. The
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injection was delivered using a fresh, sterile 21 gauge needle just below the angle of 
the acromion and inserted until the needle tip touched the intra-articular cartilage.
The fluid was then delivered in a bolus and the needle removed and safely discarded 
(Saunders 2002).
Control subjects and those with a frozen shoulder who had agreed to be part of the 
study but did not wish to receive and injection (from here on called the non injection 
group) had baseline measurements only and no intervention. All tests including the 
modified matchstick test, pressure algometry and surface EMG were conducted again 
4 weeks after baseline measurements and injection. Again the procedure is the same 
as that described for experiment 1.
3.7 Data Analysis
3.7.1 Data Analysis for Experiment 1 
Data Reduction
Following the procedure the first step for all outcomes was to calculate the difference 
between the scores for the affected and unaffected sides. The calculation to 
determine the difference between the affected and unaffected side was based on the 
hypothesis which stated that vasomotor and sensory trophic changes would be 
greater, therefore the score for the unaffected side was subtracted from the affected 
side. In the case of the control group, the difference values were calculated by 
matching to the experimental groups, therefore the values for the control group are 
slightly different depending on whether the group has been matched to the cervical 
radicular or frozen shoulder group. Alternatives for the calculation of the control 
group differences were considered, including arbitrarily subtracting all left sides 
from right sides, calculating the first half of the group as left from right and the 
second half as right from left and vice versa. However the matching procedure 
chosen was considered to have the least error variance (Holder 2007-statistician 
advice).
The decision to match the control group to each experimental group was made 
because it was important to analyse each experimental group in comparison to its 
control rather than make comparisons across 3 groups where one part of the analysis
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would be between 2 experimental groups. Comparisons between 2 experimental 
groups would not be made in clinical practice.
Modified Matchstick Test
Following the procedure, residual skin compression at 5 and 10 minutes was 
measured in each deltoid muscle. A range of scores for each arm from 0 to 5 could 
be recorded. The difference between the scores for the affected and unaffected side 
were calculated such that for each subject a score that ranged from -5  to +5 was 
obtained.
Pressure Pain rating
Following the procedure each subject reported their pain score between 0 to 10 using 
the numerical rating scale. The difference between the affected and unaffected sides 
was again calculated and thus for each subject a score which ranged from -10  to +10 
was obtained.
Surface EMG
For the EMG scores, it had initially been envisaged that the difference between the 
normalized values would be used, however, as the EMG reliability study showed the 
reliability of the normalized values was poor (ICC=0.25), the difference between the 
peak EMG values during maximum voluntary contraction were used as these had 
shown much higher levels of reliability (ICC=0.6).
3.7.2 Data Analysis for Experiment 2
Data for experiment 2 was managed in the same way as experiment 1. As baseline 
and at 4 weeks, for each outcome measure, the data was reduced as described above, 
for each of the 3 groups.
3.7.3 Statistical Data Analysis
The data from both experiments was analysed statistically using SPSS for windows, 
version 11, SPSS Inc. Normal distributions were calculated (see appendix..) and 
then the data was analysed with the appropriate test depending on the type o f data 
and the distribution obtained for each outcome (see each outcome for specific 
details).
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Experiment 1
Modified Matchstick Test and Pressure Pain Rating
For both of these outcomes significant differences between the groups were 
calculated with the Mann-Whitney U Test, a nonparametric test suitable for 
independent samples (Pallant 2005; Sim and Wright 2000). This was used because 
the data from either outcome was not normally distributed (see appendix page...), 
subjects were not randomly selected and data was not of an ordinal nature (Sim and 
Wright 2000; Hicks 1988; Pallant 2005). Comparisons between each experimental 
group and the control group were made because the main aim was to determine 
whether significant differences between each affected group and the control group 
existed, rather than a general comparison between all groups.
Surface EMG
The histograms in the appendix... (pg... fugures...) and the Kolmogorov
Smirnov significance values show that EMG values obtained from difference 
calculations between each side were not normally distributed in either o f the matched 
control groups or in the cervical radiculopathy group. However the Kolmogorov 
Smirnov significance value (which indicates normal distribution if greater than 0.05) 
was 0.186 for the frozen shoulder group showing that this was the only set of data 
obtained which followed a normal distribution. As only one measurement across all 
groups was normally distributed, and the data was not randomly selected, the Mann 
Whitney U Test was again used.
3.7.4 Sensitivity Data Analysis
The sensitivity analysis between the control group and each experimental group was 
then undertaken. The sensitivity of a diagnostic test is defined as the extent to which 
it identifies patients who have the disease for which the test is trying to determine 
(Sim and Wright 2000), where as the specificity is the extent to which the diagnostic 
test excludes those without the disease (Bland 2000). Sensitivity and specificity are 
usually in an inverse relationship and as the test increases in sensitivity, specificity 
decreases and vice versa.
In determining whether the trophic changes were sensitive indicators of cervical 
radicular or frozen shoulder pathology, sensitivity calculations outlined by Bland
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(2000) were employed (see appendix page ..)• Sensitivity calculations were 
conducted using the baseline that those in the experimental groups were disease 
positive as detected by the inclusion criteria outlined in section 3.2.2 as no gold 
standard diagnostic criteria for frozen shoulder or cervical radiculopathy exists. As 
recommended by Ajetunmobi (2002), all subjects were exposed to both the original 
method of diagnosis as well as the new trophic change tests. Also in both 
experimental groups, the subjects recruited were representative of subjects with all 
stages o f each condition and no pre-selection had been employed.
As the aim of this study was to determine whether a clinical trophic changes could be 
sensitive indicators of cervical radicular or frozen shoulder pathology, it was 
considered important to choose a cut off value for sensitivity which could be 
identified easily by clinicians in practice, for all 3 outcomes measured (Stewart 
2002). For the modified matchstick test the cut off value chosen was +2 on a scale of 
-5  to +5. A positive value was used as this reflects the hypothesis that trophic 
changes would be greater on the affected side. A cut off value of +2 was considered 
to be appropriate for the modified matchstick test as it was felt that it could be easily 
identified. Unfortunately as no previous sensitivity studies in this field had been 
carried out, this value was somewhat arbitrary. Higher values were considered but it 
was felt that these may be excessively high and may exclude some cases at the 
second measurement point at 10 minutes.
For the NRS score following algometry, a cut off point o f +2 was also used (i.e. a 
difference between affected and unaffected sides o f +2 on a -10  to +10 scale). This 
was used because a difference in pain score of +2 points is often considered to be 
clinically relevant following treatment, though clearly clinically relevant pain scores 
vary between conditions and clinicians in different situations. The literature was 
searched to determine whether data could be found to support an appropriate pain 
scale cut off point. However no data could be found to guide this decision.
It is well known that the maximum voluntary contraction varies widely between 
individuals (Winter 1991) therefore the cut off value was calculated as a ratio rather 
than an absolute value. The ratio between the 2 sides was calculated by dividing the 
affected side score by the unaffected score.
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The cut off value for the EMG data was calculated by transforming the difference 
between the affected and unaffected sides into a ratio. This was done by the 
following calculation: Affected Side EMG Score -1
Unaffected Side EMG Score
This calculation was used as it was easy to convert this value into a percentage for 
use in clinical practice by multiplying the ratio by 100 (see appendix A 2...for further 
details).
As the hypothesis stated that the maximum voluntary contraction would be reduced 
on the affected side in comparison to the unaffected side, ratio values of less than 1 
were considered in determination of the sensitivity value. Calculations with a ratio
value of 0.5 and 0.75 can be seen in the appendix-pg for both cervical
radiculopathy and frozen shoulder. It was felt that as EMG varies widely between 
individuals a clear et off value was required for clinical use, there the cut off of 0.5 
was thought to be more clinically appropriate than 0.75.
3.7.5 Statistical Analysis for Experiment 2
For experiment 2, data was analysed statistically with a Wilcoxon Signed Rank Test, 
a non parametric test suitable for paired samples, because subjects were not 
randomly selected and with the exception surface EMG for the injection and non 
injection groups, the data was not normally distributed (see Kolmogorov Smirnov 
significance values and the distribution histograms for all outcomes page...). The 
data from the modified matchstick test and the pressure pain rating was also ordinal 
in nature data and therefore non parametric analysis was also most appropriate.
Summary
This chapter has described the participants, equipment and procedures used in the 
study as well as the methods to analyse the data. The results will be described in the 
next chapter.
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CHAPTER 4
RESULTS
Introduction
As stated in Chapter 1, experiment 1 examined the sensitivity of vasomotor, sensory 
and motor trophic changes in cervical radiculopathy and frozen shoulder and 
experiment 2 examined the effects of corticosteroid injection on these trophic 
changes.
The subject characteristics for the participants in each experiment are presented 
below in section 4.1 and 4.2 respectively. In each experiment vasomotor, sensory 
and motor trophic changes were measured by the modified matchstick test, pressure 
pain rating and surface EMG. For experiment 1, the results of these tests are 
reported under the heading of each trophic change in sections 4.1.2, 4.1.3, and 4.1.4 
respectively. The results of the sensitivity analysis are reported in section 4.1.5 and 
the results for experiment 2 are shown in section 4.2. The implications of the results 
are briefly discussed in this section and further discussed in Chapter 5 (pg...) and the 
data analysis methods used can be seen in the previous chapter on page ...
4.1 Results for Experiment 1
Study Aim: The aim of experiment 1 was to determine whether clinical tests of 
vasomotor, sensory and motor trophic changes were sensitive indicators of frozen 
shoulder and cervical radicular pathology.
The research hypotheses stated that there would be a significant difference between 
trophic changes detected in cervical radiculopathy and frozen shoulder when 
compared to a control group, but that these differences would only be sensitive 
indicators of pathology in the frozen shoulder group, hypothesized because of the 
correlation between trophic changes and inflammation. In order to answer the study 
question, differences between the outcomes investigated in each of the experimental 
groups were compared to the control group, and then sensitivity analysis was 
performed.
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Overall the results show that the trophic changes are not sensitive indicators of 
pathology in cervical sensory radiculopathy or frozen shoulder. Significant 
differences between the frozen shoulder and the control groups did exist for all 
trophic changes measured (except the modified matchstick test at 10 minutes), but 
these do not appear to be clinically relevant.
4.1.1 Subject Characteristics
The number of subjects recruited in experiment 1 is shown in table 8 below along 
with the mean ages. The mean ages demonstrate that the control group was well 
matched to both experimental groups particularly the cervical radiculopathy group. 
The standard deviation also shows that there was less age variance in the frozen 
shoulder group, which supports suggestions made by Cyriax (1983) that age range 
for frozen shoulder falls between 40 and 60 years.
A one-way ANOVA was conducted to determine whether there were significant 
differences between age across the 3 groups in experiment 1 but none were shown, 
(P=0.136). A Kruskall-Wallis test was also conducted which showed that there were 
no significant gender differences across the 3 groups in experiment 1 (P=0.989). A 
non-parametric test was used because the data was nominal.
Table 8: Mean Age and Gender of Subjects Recruited for Experiment 1
Group
Male Female Total Mean Age 
(Years)
Age
Standard
Deviation
Control Group 13 17 30 50.63 15.575
Cervical Radiculopathy Group 14 17 31 50.81 15.079
Frozen Shoulder Group 14 18 32 56.75 9.762
Total 41 52 93 52.80 13.821
4.1.2 Vasomotor Trophic Changes
The modified matchstick test was used to investigate vasomotor changes by 
measuring the existence of subcutaneous oedema, which was represented by the
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presence of residual skin compression at 5 and 10 minutes. Figures.... in Appendix 
A2 page... demonstrate the frequency of residual compression scores following the 
modified matchstick test and show that none of the data was not normally distributed 
for all 3 groups. It was therefore inappropriate to describe the data using mean or 
standard deviation statistics as these methods are reserved for data that are measured 
on at least an interval scale, which exhibit a symmetrical distribution (Sim and 
Wright 2000). It is recommended that ordinal, non normally distributed data is 
represented by the median and interquartile range (IQR), and these values for the 
modified matchstick test for all groups (experimental and matched control) can be 
seen in appendix ..box plots figures , and in table pg..???.
Figure 3 shows the median value and interquartile range for the modified matchstick 
test at 5 minutes for the frozen shoulder group and the relevant matched control 
group. The black line in the centre of the box plot shows the median value, the 
beige box shows the interquartile range (between the 25th and 75th percentile) 
demonstrating where 50% of the scores lie. The whiskers extending from the box 
demonstrate the minimum and maximum values (starred values represent outliers).
At the 5 minute measurement point, the interquartile range for the control group 
show less variability than the frozen shoulder group, however there is no difference 
between the median values. The interquartile range for the frozen shoulder group 
continues to show wider score variability at the 10 minute measurement point, where 
as the control and cervical radiculopathy groups do not (see figures .pg.. .appendix 
A2). The results of significance testing for the modified matchstick test at 5 and 10 
minutes for the experimental groups and the matched control groups are shown in 
table 9, the only significant result occurs between the control and the frozen shoulder 
group at 5 minutes P<0.05. These findings suggest that subcutaneous oedema may 
be present in the frozen shoulder group.
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Figure 3: Box Plot showing the Interquartile range, median, minimum and 
maximum values for the frozen shoulder group and the control group for the 
modified matchstick test at 5 minutes. (Control Group N=30; Frozen Shoulder 
Group N=32; Statistical Significance P=0.033)
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Table 9: Significance and Z values for All Groups for the Modified Matchstick 
Test
Modified Matchstick Test (MMST) Z Value Significance
Value
Control Group Vs Cervical Radiculopathy 5 minutes -1.425 P=0.154
Control Group Vs Cervical Radiculopathy 10 minutes -1.250 P=0.211
Control Group Vs Frozen Shoulder 5 minutes -2.134 P=0.033
Control GroupVs Frozen ShoulderlO minutes -0.794 P=0.427
4.1.3 Sensory Trophic Changes
Sensory trophic changes were investigated by measuring hyperalgesic responses to 
pressure. Pressure was delivered to the motor point in each deltoid muscle with an
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algometer and the hyperalgesic response was measured on a 0-10 numerical rating 
scale (NRS). The difference between each side was calculated and the resultant NRS 
score obtained thus ranged -10  to +10 for each subject. Interquartile ranges and 
median values were again used to represent the data because the data was considered 
to be of an ordinal nature and the NRS scores were not normally distributed (see 
Appendix A2 pg ..figure..). The control group interquartile ranges showed low score 
variation (see table ...pg for median and IQR values and box plots pg....), where as 
the experimental groups (particularly the cervical radiculopathy group) showed more 
variation.
The results of significance testing for the each experimental group and the matched 
control groups are shown in table 10. The results show that there is a significant 
difference in the pain score reported between the cervical radiculopathy and frozen 
shoulder group in comparison to the matched control groups (P< 0.05 in both 
groups), with the pain scores higher on the affected side, demonstrating hyperalgesia 
in both experimental groups.
Table 10: Significance and Z values for All Groups for Pressure Pain Rating
Numerical Rating Scale Z Value Significance Value
Control Group Vs Cervical Radiculopathy -3.687 P=0.000
Control Group Vs Frozen Shoulder -2.971 P=0.003
4.1.4 Motor Trophic Changes
Motor trophic changes were investigated by measuring the difference in the 
maximum voluntary contraction between each side with surface EMG (peak 
amplitude parameter). Median and interquartile ranges were again used (see 
figures.. .pages .. .Appendix A2) as only one set o f EMG data from the frozen 
shoulder group was normally distributed (see appendix A 2 ... p g .. .figs... and the 
Kolmogorov Smirnov significance values pg ..). (N.B. Mean, Standard Deviation 
and Standard error can be found in appendix.. . .for information purposes only). 
Generally the interquartile range for the matched control groups and the cervical 
radiculopathy groups were similar (with values of 113mv, 107mv and 109mv 
respectively) showing relatively large score variation. However the IQR for the
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frozen shoulder group showed much less variability at 69mv. The median value for 
the frozen shoulder group is -51.50mv which, when compared to the matched control 
group value of-5.50m v, indicates that electrical activity is less in the frozen shoulder 
group when compared to the control group. The results o f significance testing 
between groups can be seen in table 11 and the difference between the control and 
the frozen shoulder group is statistically significant (P<0.05). No difference between 
the control and the cervical radiculopathy group exists which suggests that motor 
changes are present in the frozen shoulder group alone.
Table 11: Significance and Z values for All Groups for Surface EMG
MVC EMG Z value Significance Value
Control Vs Cervical Radiculopathy -0.866 P=0.387
Control Vs Frozen Shoulder -2.705 P=0.007
Summary
In summary there was a significant difference between the affected and unaffected 
sides in the frozen shoulder group in all outcomes when compared to the control 
group except for the modified matchstick test at 10 minutes. This suggests that 
vasomotor, sensory and motor trophic changes were present in the frozen shoulder 
group in the form of subcutaneous oedema, hyperalgesia and reduced electrical 
activity. It appears that in the frozen shoulder group, subcutaneous oedema can be 
detected when measured 5 minutes following compression, but is no longer 
detectable at 10 minutes. One interpretation may be that the existence of 
subcutaneous oedema is mild in frozen shoulder which may be why it is only 
detectable at 5 minutes post compression. The results also suggest that in cervical 
radiculopathy the only trophic change present is hyperalgesia.
4.1.5 Sensitivity Analysis
To determine whether the significant differences obtained were sensitive indicators 
of pathology, sensitivity analysis was performed. Sensitivity values for all outcomes 
can be seen in table 10. As discussed in the data analysis section pg.., the cut off 
point for the modified matchstick test and pressure pain rating was +2, based on the 
hypothesis that trophic changes would be greater in the affected side. This value was
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considered to be the lowest cut off which could be used and thus no further analysis 
is shown.
For the EMG outcome, the hypothesis stated that the maximum voluntary contraction 
would be reduced on the affected side in comparison to the unaffected side in the 
experimental groups. Calculations with cut off values of 0.5 and 0.75 were
conducted (see appendix-pg for both cervical radiculopathy and frozen shoulder).
The results in table 11... show that using a ratio cut off value of 0.5, the sensitivity in 
cervical radiculopathy was 0.16 and in frozen shoulder was 0.25. If a higher ratio cut 
off value o f 0.75 was used, the sensitivity increased to 0.42 in cervical radiculopathy, 
and 0.59 in frozen shoulder.
Table 12: Sensitivity Calculations for each Outcome in Cervical Radiculopathy 
and Frozen Shoulder. (Modified Matchstick Test=MMST; Numerical Rating 
Scale =NRS; Electro my ography=EMG)
Test Test Sensitivity in 
Cervical Radiculopathy
Test Sensitivity in 
Frozen Shoulder
MMST 5 minutes 0.06 0.31
MMST 10 minutes 0.16 0.28
NRS 0.39 0.41
EMG Sensitivity (cut off 0.5) 0.16 0.25
EMG Sensitivity (cut off 0.75) 0.42 0.59
The hypothesis in section 2.6 stated that trophic changes would be sensitive 
indicators o f frozen shoulder pathology but not of cervical sensory radiculopathy. 
However the results above show that none of the tests in either condition are 
sensitive indicators of pathology.
(For information purposes, appendix... pg... also shows the specificity calculations 
for the 3 tests. These demonstrate that although sensitivity is low, specificity is high, 
however as this test is not likely to be used in general musculoskeletal screening to 
exclude those without the disease these values are not relevant).
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4.2 Results for Experiment 2
Study Aim: The aim of experiment 2 was to determine the effects of cortico-steroid 
injection on trophic changes in frozen shoulder.
The hypothesis for experiment 2 stated that there would be a reduction in vasomotor 
and sensory trophic changes and an increase in motor changes in subjects with frozen 
shoulder following injection. To determine whether these changes had occurred in 
subjects with frozen shoulder the differences between the affected and unaffected 
shoulders were calculated, before and 4 weeks after injection for each trophic change 
investigated. The difference between the base line and the 4 week measurements 
were also calculated for the control group and for the subjects in the frozen shoulder 
group who decided not to have an injection (the non injection group).
4.2.1 Subject Characteristics
The number of subjects recruited in experiment 2 is shown in table 13 below along 
with the mean ages. A one-way ANOVA was conducted to determine whether there 
were significant differences between age across the 3 groups in but none were shown 
(P=0.085). A Kruskall-Wallis test was conducted which showed that there were no 
significant gender differences across the 3 groups (P=0.904), again a non-parametric 
test was used because the data was nominal.
Table 13: Mean Age and Gender of Subjects Recruited for Experiment 2
Group Male Female Total Mean Age 
(Years)
Standard
Deviation
Injection Group 7 10 17 58.12 8.470
Non-injection Group 5 5 10 59.00 10.220
Control Group 13 17 30 50.63 15.575
Total 25 32 57 54.33 13.359
4.2.2 Vasomotor, Sensory and Motor Tropic Changes, Results for Experiment 2
The median and interquartile ranges were again used to demonstrate the findings 
because the data was not normally distributed (except for the EMG values). These 
can be found in table... in appendix A2... pg... .and shown in figure... pg... As may 
be expected the interquartile range for the modified matchstick test and the numerical
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rating scale showed low variability (IQR=0) in the control group, but again the 
injection and non-injection groups showed more score variance. Again the EMG 
scores on maximum voluntary contraction pg...showed generally high variability 
through out all groups see figure...pg...
Observation of the baseline median EMG values in all 3 groups shows that the 
measurements were all negative. Taking into account how the difference scores were 
calculated (i.e. affected side minus unaffected side) this indicates that at baseline the 
maximum voluntary contraction on the unaffected side was consistently greater than 
on the affected side resulting in a negative finding. After the 4 week period, the 
median value for both the injection group and the non injection group had changed 
from negative to positive indicating that the affected side maximum voluntary 
contraction had become greater than the unaffected side (injection group median 
change from -48.00 to 12.00mv; non-injection group median change from -64 to 
2.00mv). The median value for the control group had also changed from -5.50 to -  
2.00mv, which showed a similar trend but remained negative indicating that the 
unaffected side maximum contraction was still greater.
A Wilcoxon Signed Rank Test was used to determine whether the differences 
between measurements at baseline and 4 weeks after injection, were significant for 
each trophic change. Comparisons between baseline measurements and those taken 
at 4 weeks were also performed for the non-injection and the control group to 
determine whether significant differences were unique to the injection group alone. 
Table 14 shows that there were no significant differences in vasomotor and sensory 
trophic changes between the baseline measurements and those taken at week 4, as 
measured by the modified matchstick test or pressure pain rating in any of the 
groups. However the difference in motor trophic changes as measured by EMG was 
statistically significant between baseline and week 4 in the injection group 
(P=0.001). Interestingly, the difference between the baseline and week 4 was also 
significantly different in the control group (P=0.045) (but there were no significant 
differences in the non-injection group see table 14). To ensure that these differences 
were not related to the unequal size of the sample (i.e. n=l 7 in the injection group, 
n=30 in the control group) a Wilcoxon test was conducted on the results obtained 
from the first 17 control subjects. The results can be seen in appendix., pg.. and
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showed that this control group also demonstrated a significant difference between the 
baseline and the 4 week measurement point (P=0.033). Though the injection group 
results follow the hypothesis that motor trophic changes increase following injection, 
the finding that this also occurs in the control group demonstrates that this finding 
cannot be relied upon and lacks clinical significance. In summary, the conclusion 
drawn is that there is no clinically significant difference between trophic changes 
before and after cortico-steroid injection.
Table 14: The results of significance testing between initial scores and those 
taken 1 month later for all groups in experiment 2. (Modified Matchstick 
Test=MMST; Numerical Rating Scale =NRS; Electromyography=EMG)
Control Group Non Injection 
Group
Injection Group
Outcome Z Value P Value Z Value P Value Z Value P Value
MMST 5 minutes -0.317 0.751 -0.106 0.916 -1.083 0.279
MMST 10 minutes -0.816 0.414 -1.069 0.285 -1.274 0.203
NRS -1.530 0.596 -1.841 0.066 -0.557 0.577
EMG -1.2006 0.045 -1.070 -0.285 0.432 0.001
Results Summary
Thus overall it appears that trophic changes are not sensitive indicators of pathology 
and are not altered by anti-inflammatory medication. The implications of these 
findings are discussed further in Chapter 5.
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CHAPTER 5
DISCUSSION AND CONCLUSIONS 
Introduction
This final chapter is divided into two parts, evaluating the results of experiment 1 and 
2 respectively. The aim of each study is be re-stated, the methodology is be briefly 
outlined to add clarity and the results are discussed in detail. Finally the chapter ends 
with conclusions and recommendations for further study.
5.1 Overview of Experiment 1
The aim of study 1 was to determine whether clinical tests of vasomotor, sensory or 
motor trophic changes were sensitive indicators of cervical radiculopathy or frozen 
shoulder.
Experiment 1 was a non-randomized, controlled study with 93 subjects, (control 
n=30, cervical radiculopathy n=31, frozen shoulder n=32). Trophic changes were 
measured in the C5 segment (specifically over the lateral aspect of the shoulder), the 
area to which pain normally refers in C5 radiculopathy and frozen shoulder. 
Measurements were taken from each shoulder and the difference between the 
affected and unaffected side was calculated for each outcome tested. Clinical tests 
were used to ensure that if  trophic changes were found to be sensitive indicators of 
pathology, they would be low cost, easy to perform and would thus be able to have a 
high impact to a wide range of practitioners.
Vasomotor trophic changes were investigated indirectly by measuring the presence 
o f subcutaneous oedema in the C5 segment with the modified matchstick test (a 
method which involved placing a cylindrical tube against the skin and exerting a 
known force to the free end with an algometer, resulting in skin compression). 
Residual skin indentations were measured at 5 and 10 minutes following 
compression of 5N, at a site in each deltoid muscle, 1cm above the deltoid tuberosity. 
This newly modified method showed substantial levels of agreement (as defined by 
Landis and Koch (1977) for Kappa comparisons) between baseline and
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measurements at 4 weeks, (level of agreement at 5 minutes £=0.79; at 10 minutes £= 
0.61) thus demonstrating good to high reliability (see method pg..).
Sensory trophic changes were measured with the numerical rating scale following 
algometer pressure of 35N, within the C5 segment at the site of the motor point in 
each deltoid muscle. Reliability of this technique was demonstrated by comparison 
of the levels of agreement between measurements taken at baseline and at 4 weeks 
and again substantial levels of agreement were shown (£=0.93) (Landis and Koch 
1977).
Motor trophic changes were measured using surface electromyography in the C5 
segment (deltoid muscle). The root mean square peak amplitude parameter of the 
maximum voluntary contraction was used. Both the maximum voluntary contraction 
(MVC) and a normalized value following low effort muscle activity (abduction 1kg) 
were trialled, however as reliability values were particularly low for the normalized 
value, (intra-class correlation coefficient = 0.25) this was excluded from the main 
experiment and the MVC method demonstrating moderate reliability was used 
(intraclass correlation coefficient = 0.60).
5.2 Discussion of the Results of Experiment 1
The results showed that in subjects with cervical radiculopathy, sensory trophic 
changes were the only findings shown to be significantly different to the control 
group (P=0.000). However in the frozen shoulder group, the results showed that 
vasomotor changes measured with the modified matchstick test at 5 minutes, sensory 
changes tested by pressure pain rating and motor changes tested with EMG of the 
maximum voluntary contraction were all significantly different when compared to 
the control group (P=0.033, P=0.003 and P= 0.007 respectively). Despite the 
statistically significant difference between the control and the experimental groups, 
these differences were not clinically relevant. This was further shown by the 
sensitivity analysis which demonstrated that trophic changes were not sensitive 
indicators o f pathology in either group. Sensitivity analysis using a cut off value of 
+2 for vasomotor changes at 5 minutes showed values o f 0.06 and 0.31 for the 
cervical radiculopathy and frozen shoulder groups respectively, sensitivity analysis at 
10 minutes was similarly low. A lower cut off value would have yielded higher
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sensitivity values but this was not considered clinically useful and thus the cut off 
value was kept at +2.
The sensitivity of pressure pain rating was slightly higher at 0.39 and 0.41 for 
cervical radiculopathy and frozen shoulder respectively. Though the sensitivity was 
slightly higher for sensory trophic changes, these values were not considered to be 
clinically useful to assist diagnosis. The cut off value of +2 was again considered to 
be clinically appropriate, though it is acknowledged that this value is based on 
clinical experience. A literature search to determine the appropriate level for the 
pain score ‘cut o ff  revealed that the clinical significance of pain scales such as the 
NRS or VAS has not yet been studied widely. Ernst et al, (1998) considered the 
clinical significance of pain scores following administration of cortico-steroid 
medication for the management of pain following herpes zoster, and concluded that 
the clinical significance of a reduced pain scores, has yet to be determined. Thus a 
cut off value o f less than +2 was not considered to be clinically relevant and 
therefore no further analysis was undertaken.
Sensitivity analysis of EMG from maximum voluntary contraction was conducted 
using a ratio between affected and unaffected side rather than an absolute value (see 
method p g ... for details). The cut of value which was considered to be most 
clinically relevant again revealed poor sensitivity values of 0.16 and 0.25 for the 
cervical radiculopathy and frozen shoulder groups respectively. Raising the cut of 
value did yield significantly more sensitive results (see sensitivity table 12, pg..), 
however this would also have raised the likelihood false positives and reduced the 
clinical relevance, therefore the lower cut off value was maintained. It was 
acknowledged in the section 3.4 that the reliability of surface EMG in this study was 
on the lower limit of acceptable reliability. If these results had been shown to be 
sensitive indicators of pathology then the usefulness o f findings produced would 
have to be considered in light of the fact that the EMG test was only moderately 
reliable. However as the results were not shown to be sensitive, further discussion is 
not required.
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Although studies to date such as Giamberardino et al, (2005), Wesselman and Lai 
(1997), Galletti et al, (1990) and Gunn and Milbrandt (1978), have stated that trophic 
changes can be used as indicators of pathology in visceral, muscuoskeletal and 
radicular pathology, the results of this study suggest that vasomotor changes tested 
by measuring subcutaneous oedema, sensory changes tested by pressure pain rating 
and motor changes tested with surface EMG during maximum voluntary contraction 
are not sensitive indicators of neuromusculoskeletal pathology such as cervical 
radiculopathy and frozen shoulder.
In Chapter 2 page., the study by Leis et al, (2004) was discussed which hypothesized 
that flare response and plasma extravasation may have different mechanisms. This 
hypothesis arose following the finding that skin blood flow measurements indicating 
flare response were found in complex regional pain syndrome patients, but that 
plasma extravasation was not. It is therefore possible that other trophic changes may 
be sensitive indicators of pathology and thus generalised statements cannot be made 
regarding the sensitivity of all trophic changes.
5.3 Limitations of Experiment 1
The use of convenience or consecutive rather than random sampling may mean that 
the sample recruited was not truly representative o f the range of subjects with 
cervical radiculopathy or frozen shoulder. Randomization would have been superior, 
but difficulties in obtaining the required sample size prevented this method. The lack 
of blinding was also a limitation of this study and could have led to the introduction 
of assessment bias (Bland 2000), particularly when determining the outcome of the 
modified matchstick test. Unfortunately because of the constraints of the study, 
(financial and time), the risk of assessment bias could not be excluded. It has been 
suggested that non-blinded examiners may bias the results positively or, in an 
attempt to compensate may in fact, bias the results negatively, thus both of these 
scenarios must be considered with respect to the results o f this study.
As discussed in the data analysis section, when determining the difference between 
the affected and unaffected side, the control group was matched to the experimental 
group. A variety o f arbitrary calculations for the control group were considered such 
as subtracting the left side from the right side in the first 50% of subjects and then
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reversing this for the second 50% and vice versa. All of the calculations revealed the 
same significant results (i.e. different z and p values, but the same significant or non 
significant outcome). The only change occurred when all left sides were taken from 
all right sides in the control group. This calculation revealed no significant 
differences between groups in all outcomes except for the modified matchstick test at 
5 minutes for the frozen shoulder group, which was significant when this process 
was used. However, as outlined in the data analysis section, exact matching to the 
affected group was recommended by the consulting statistician (Holder 2007) to 
reduce the effects of error variance, and thus this procedure was maintained.
Finally an increase in the amount of pressure used in the modified matchstick test 
may have resulted in more significant values particularly for the sensitivity analysis. 
However when testing for subcutaneous oedema with the modified matchstick test, 
the amount o f pressure used had to be kept to a relatively low level to ensure that 
skin was not broken during pressure by the cylindrical plastic tube. Though higher 
pressure may have been useful it was not considered appropriate as the aim was to 
develop a clinical test to be used with a variety of patients some of whom would not 
tolerate this pressure due to increases in pain and some of whom may have frail skin 
which could be damaged by the test.
In summary significant differences in vasomotor, sensory and motor trophic changes 
between the control and the frozen shoulder group were found, but in the cervical 
radiculopathy group only sensory changes were significantly different. However 
none of these changes were sensitive indicators of pathology and are thus not 
clinically relevant.
5.4 Overview of Experiment 2
The aim of experiment 2 was to determine whether trophic changes were 
significantly different after corticosteroid injection into the shoulder joint in subjects 
with frozen shoulder.
17 subjects with frozen shoulder were recruited for shoulder joint injection from the 
pool o f 32 subjects in study 1. 10 subjects were also recruited as a further control 
from study 1 who did not consent to injection but who agreed to undergo tests at
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baseline and 4 weeks later (non injection group). Comparisons of both groups were 
made to the control group (n=30). All subjects were subjected to the same tests used 
in experiment 1. The injection group then underwent a shoulder joint injection and 
then all groups were subject to measurements again at 4 weeks.
5.5 Discussion of the Results of Experiment 2
The results show that there were no significant differences between baseline 
measurements and those taken at 4 weeks for the modified matchstick test and 
pressure pain rating, which suggests that injection has no effect on vasomotor and 
sensory trophic changes. However the finding that EMG scores are significantly 
different in both the injection group and the control group (P= 0.001 and 0.045 
respectively) suggests that these results cannot not be relied upon as a basis from 
which to draw conclusions regarding the effects of cortico-steroid on motor changes. 
The finding that motor trophic changes were significantly different in the control 
group was unexpected as analysis o f the control group when testing reliability, 
comparing the baseline measurements with those at 4 weeks, with a paired samples T 
Test, had shown no significant difference between the 2 time periods P=0.091 
(pg.. .appendix). However in the control group analysis, calculations had been 
conducted by arbitrarily taking all left side values from right side values and thus 
calculations were slightly different from those conducted when the control group was 
matched to the experimental groups. In summary the results of experiment 2 
suggest that cortico-steroid injection has no effect on trophic changes.
5.6 Limitations of Experiment 2
As with study 1, the lack of randomization and blinding were significant limiting 
factors in this study. The power calculations for study 2 showed that 17 subjects per 
group were required however due to drop outs the non injection group was reduced 
to 10 subjects which increased the risk of a type 2 error (i.e. concluding that there 
was no difference between groups when they are in fact different) (Pallant 2001).
Finally if the results had shown that there were significant differences between 
baseline and week 4 measurements after injection, the inclusion of formal methods to 
monitor correlations between trophic changes, general pain levels and functional 
recovery may have been useful.
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5.7 Conclusions and Recommendations
Experiment 1 aimed to determine whether trophic changes were sensitive indicators 
of neuromusculoskeletal pathology in cervical sensory radiculopathy and frozen 
shoulder. Though significant differences were shown to exist between the 
experimental and the control groups, these differences were not shown to be sensitive 
indicators of pathology in frozen shoulder or cervical sensory radiculopathy. The 
results of this study contradict the suggestions made by other authors in the field that 
trophic changes could be useful in the diagnostic process. Further work to 
investigate the sensitivity of other trophic changes such as plasma extravasation may 
be useful to determine whether certain changes are more sensitive than others.
The aim o f experiment 2 was to determine whether cortico-steroid injection had an 
effect on the existence of trophic changes, particularly to determine whether 
vasomotor and sensory trophic changes were reduced and motor changes were 
increased after injection. The results from the first experiment showed that there was 
a significant difference between the control and the frozen shoulder group in 3 out of 
4 of the trophic changes investigated, however generally the results of experiment 2 
do not reveal a significant change after injection. A significant difference in motor 
trophic changes was found in the injection group, however as significant differences 
in the control group between baseline and measurement at 4 weeks were also found 
these findings were not considered to be clinically relevant. Overall it does not 
appear that the trophic changes investigated in this study are significantly changed by 
administration o f corticosteroid, which also suggests that trophic changes do not 
appear to be useful as a sign of recovery. Further studies to determine whether 
trophic changes are reduced following injection in the long term may be useful, as 
well as other studies investigating other anti-inflammatory medication.
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APPENDIX A l
A l.l  Pilot Study Cervical Spine Inclusion Criteria
The pilot study was conducted to determine the inclusion criteria for cervical spine 
radiculopthy. A variety of signs and symptoms were assessed for subjects referred 
with C5 Cervical Radiculopathy and the results are listed below for the 10 subjects 
screened in table Al . l  to table A l .3
Table: A l.l  Pain Location, Pain Score and Shoulder Pathology for Cervical 
Radicular pilot study group
Subject
Number
Pain Location NRS Score Passive
Movements
Resisted
Movements
Shoulder
Pathology
1 C5 3 N N N
2 C5 4 N N N
3 C5 5 N N N
4 Diffuse 3 N Y N
5 C5 5 N N N
6 C5 5 N N N
7 C5 6 N N N
8 C5 7 N N N
9 C5 9 N Y N
10 C5 4 N N N
Table: A1.2 Pain on Movements of Cervical spine and Joint Palpation for 
Cervical Radicular Pilot Study Group
Subject
Number
Pain on 
Rotation 
towards 
affected side
Pain on side 
flexion 
away from 
affected side
Pain 
began 
in neck
Pain began 
in arm
Pain on 
palpation 
of multiple 
C spine jts
Pain on 
palpation 
of C5 jts 
only
1 N N Y N Y N
2 Y N Y N Y N
3 Y N Y N N Y
4 N N Y N Y N
105
5 N N Y N Y N
6 N N Y N Y N
7 Y N Y N Y N
8 Y Y Y N Y N
9 Y Y N Y Y N
10 N N Y N Y N
Table: A1.3 Sensory/motor disturbance from Cervical Radicular pilot study 
group
Subject
number
Reflex loss Myotome
weakness
Parasthesia Anaesthesia
1 N N N N
2 N N N N
3 N N N N
4 N N N N
5 N N N N
6 N N N N
7 N N N N
8 N N N N
9 N N Y Y
10 N N N N
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A1.2 Modified Matchstick Test Pilot Study Procedure and Data
The pilot study was conducted to determine the most appropriate compression force 
required to test for subcutaneous oedema and the time it took for the skin 
compression to return to normal.
Procedure
5 volunteers subjects with no history of cervical or shoulder pathology were 
randomly selected from 30 staff working in an NHS outpatient department. Subjects 
were positioned in a relaxed, supported, seated position with feet placed on the floor, 
knees and hips at 90 degrees. The skin overlying the deltoid muscle, 1cm proximal 
to the deltoid tuberosity was identified and the plastic guide tube was placed 
vertically on the skin. Compression was applied to the skin with an algometer 
(Wagner Instruments, USA), via the free end o f the plastic guide tube in increments 
o f 2.5N, 5N, 7.5N and ION. The algometer was fitted with a rubber stop to prevent 
sliding between the algometer and the compression tube. To determine the 
normative data for the length of time for which compression should be observed, the 
subjects were again exposed to skin compression (3 hours later) and the time taken 
for skin recovery was observed following compression with force levels of 5N.
Results
The results for the ideal compression force are shown in table A1.4. In summary 
force over 5N tended to be considered painful by some volunteer subjects, because of 
the small surface area of the guide tube, even though it was blunt. In contrast a force 
o f 2.5N did not leave a consistent skin indentation, therefore a force of 5N was 
deemed most suitable for this study. Timing the skin recovery from compression 
can be seen in table A l .5. The average time for skin indentation following 
compression via algometry of 5N was 4.9 minutes (4.8 minutes for the right and 5 
minutes for the left side). Therefore it was determined that in the main experiment 
indentation marks would be observed at 5 minutes following the test. As 2 subjects 
also had evidence of residual skin indentation at 6 minutes, it was decided that a final 
cut off point at 10 minutes would be used to determine subjects with marked oedema.
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Table A1.4 The Results of the Pilot Study to determine optimum level of 
compression force for the modified matchstick test.
Boxes which state ‘unable to complete’ indicated where the test was too painful to 
proceed.
Force (N) Subject 1 
(minutes)
Subject 2 
(minutes)
Subject 3 
(minutes)
Subject 4 
(minutes)
Subject 5 
(minutes)
2.5N 2 1 1 2 3
5.ON 6 5 3 4 6
7.5N 15 Unable to 
complete
Unable to 
complete
9 11
ION Unable to 
complete
Unable to 
complete
Unable to 
complete
Unable to 
complete
Unable to 
complete
Table A1.5 The Results the of Pilot Study to determine the time taken for skin 
compression to return to normal following the modified match stick test.
Subject number Right Deltoid 
Compression (minutes)
Left Deltoid Compression 
(minutes)
1 6 6
2 5 5
3 3 4
4 4 4
5 6 6
Mean 4.8 5
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A1.3 Standards for Agreement
Strength of Agreement using the Kappa Coefficient
Landis and Koch (1977)
0 Poor
0.01-0.20 Slight
0.21-0.40 Fair
0.41-0.60 Moderate
0.61-0.80 Substantial
0.81-1.0 Almo st Perfect
Strength of Agreement using the Intraclass Correlation Coefficient
Portney and Watkins (1993)
Below 0.75 poor to moderate reliability 
0.75 to 0.90 good to excellent reliability
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A1.4: Normalization and Procedure for Surface EMG Data Collection
Normalization
To enable comparisons of electrical activity to be made between different individuals 
or different studies, a normalization procedure is commonly employed (Winter 
1991). The procedure should involve taking a reference value (such as the maximum 
voluntary contraction) and then expressing the test EMG value as a percentage of this 
value. Raw or processed versions of data can be used for normalization (Soderberg 
and Knutson 2000). A variety of normalization procedures have been used but there 
is still debate about the most appropriate and effective normalization procedure, with 
the rationale for the procedure being reported as ‘often based on logic or opinion’ 
(Soderberg and Knutson 2000). Four normalization procedures have been described 
in the literature which include the:
a) Isometric Maximum Voluntary Contraction (MVC) (Yang and Winter 1984)
b) Sub-maximal Voluntary Contraction (Yang and Winter 1983)
c) Peak EMG value obtained during a dynamic activity (Knutson and Richards 
1979) and
d) Mean EMG value obtained during a dynamic activity (Winter and Yack, 
1987).
Studies have shown wide ranging levels of reliability for all normalization 
techniques, despite studies having similar levels o f methodological quality. MVC 
and sub-maximal normalization methods were compared (Roe et al, 2006) showing 
that MVC normalization was significantly more reliable that sub-maximal 
normalization (intra-class correlation coefficient for intra-day reliability for 3 MVC 
measurements was 0.92, coefficient of variation of 13%), whereas sub-maximal 
normalization showed very poor repeatability (ICC values of 0.15 and a coefficient 
o f variation o f 29%). In contrast, Yang and Winter (1983) considered the reliability 
of MVC versus sub-maximal normalization and found that sub-maximal values were 
more reliable than MVC. The intra-class correlation coefficients across a 3 day 
period ranged from 0.59-0.81 for the MVC; 0.81-0.93 for 50% MVC and 0.87-0.95 
for 30% MVC, demonstrating the most reliability over 3 days for the 30% MVC 
contraction.
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Knutson et al, (1994) compared the MVC, peak dynamic and mean dynamic 
normalization methods using the gastrocnemius muscle in a study of 20 subjects with 
‘anterior cruciate deficient’ knees and 20 control subjects, showing that MVC 
normalization was most reliable in comparison to the mean or peak dynamic method. 
However in contrast, Morris et al, (1998) investigated the reliability of 3 
normalization procedures (MVC, peak dynamic and mean dynamic), in the rotator 
cuff muscles, using needle EMG in a small controlled study (n=5). The results 
showed that the MVC procedure had higher levels of variation on repeated testing 
(overall coefficient of variation (CV) =53%), in comparison to the peak (CV =8%), 
or mean dynamic methods (CV =12%).
In light o f variations in the literature, Soderberg and Knutson (2000) have 
recommended that MVC should be used for the normalization procedure until further 
literature supporting the optimum procedure for sub-maximal normalization is 
available. They also make a strong case that as the majority of studies have used the 
MVC normalization procedure, the results of work from MVC studies can be more 
easily compared. Following these recommendations a normalization procedure with 
the maximum voluntary contraction model, was employed. Reliability analysis was 
conducted with 20 control subjects, measuring at baseline and at 4 weeks (see 
procedure below). However, statistical analysis demonstrated that the intra-class 
correlation coefficient was very low at 0.25, and thus this procedure was not 
considered to be reliable enough to use in the main study.
Normalization Procedure Used 
Subject Position
Subjects were seated in an upright position on an adjustable plinth, with hips and 
knees at 90 degrees and feet placed in neutral on the floor as used by Roe et al,
(2006). The shoulder under test was positioned at 45 degrees of glenohumeral 
abduction in the scapula plane (elbow and wrist joint neutral).
Electrode Placement
Prior to placing the electrodes, the skin was cleaned with a mediswab alcohol wipe to 
reduce skin impedance (Kamen 2004). One electrode was placed on each deltoid
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muscle midway between the greater tuberosity and the deltoid tuberosity, parallel 
with the muscle fibres to ensure a consistent signal.
Prior to the procedure subjects were given the opportunity to practice before any data 
was collected. Following the maximum voluntary contraction data collection, 
subjects rested for a 5 minute period. A 1kg wrist weight (Reebock, USA) was 
attached to the subject’s wrist (a 1kg weight was also used by Nordander et al, 2004). 
Subjects were asked to raise the arm to 45 degrees of abduction, with the palm of the 
hand facing towards the floor, and were then asked to hold this position for 4 
seconds. Each subject was initially asked to practise this procedure twice, prior to 
data collection. Following rehearsal, each subject was then asked to perform the test 
procedure 3 times with a 30 second rest period between each contraction. The EMG 
amplitude was recorded and the average of the 3 values was then calculated.
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A1.5 Distribution of Scores for the Surface EMG Reliability Tests
This section shows the Kolmogorov-Smimov Test results and the distribution of 
scores for surface EMG Baseline and 4 week Measurements for 20 Control Subjects. 
Kolmogorov-Smimov values greater than 0.05 indicate a normal distribution and 
those less than 0.05 indicate a non normal distribution of scores. The scores for the 
MVC EMG measurements at baseline and week 4 are both greater than 0.05, and are 
thus normally distributed which is reflected in the histograms in figures Al . l  and 
A1.2.
Table A l. 6 Results of the Kolmogorov-Smirnov Test for Surface EMG at 
Baseline and 4 week for 20 control subjects
Statistic Sig.
EMG MVC at Baseline .186 .069
EMG MVC at 4 weeks .108 .200
Figure A l . l  Distribution of Scores for Surface EMG Reliability Test, Baseline 
values for 20 control subjects
Histogram
Mean = -30 9 
S td  Dev. = 76.809 
N = 20
D ifference betw een MVC
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Figure A1.2 Distribution of Scores for Surface EMG Reliability Test, 4 week 
values for 20 control subjects
H istogram
Mean = -5.45 
Std. Dev. = 36.491 
N * 20
Repeat te st difference MVC
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A1.6 Measurement Error
Surface EMG (rms)
Table A1.7 The results of One Way ANOVA to determine within subjects 
standard deviation.
Sum of squares df Mean Square
Within Groups 45206.500 20 2260.325
N.B. The standard deviation is the square root of the residual within groups mean 
square, i.e. square root of 2260.325 = 47.54. Measurement error is 2x47.54, which is 
95.08mv
The between subject variance was calculated by the statistician using the following 
calculation:
1466+2260=3726
Square root o f 3726=61.04mv
Reported within 2 standard deviations this is 2x61.04=122.08mv.
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A1.7 Patient Information Leaflets and Consent Forms
Date 28.2.06: Version 5
Information About the Study For Volunteers
1) Study Title
Investigation o f trophic changes (skin changes) in C4/5 cervical dysfunction 
(neck pain) and frozen shoulder.
2) Invitation Paragraph
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if  you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. 
Thank you.
3) What is the purpose of this study?
This research study which began in 2000 involves collecting information and testing 
patients with neck and shoulder problems to help improve diagnosis and treatment.
It is due to finish in 2005. Neck pain and frozen shoulder are common complaints 
that affect patients attending for physiotherapy and can be very difficult to diagnose 
and treat. This study looks at investigating simple changes that occur to the skin 
thickness and muscle tone to see if these simple changes can be used to aid diagnosis 
rather than sending patients for more complex tests.
4) Why have I been chosen?
Patients who have a frozen shoulder or who have neck pain that sends pain into the 
shoulder area will be asked to take part in the study. There will also be a group of 
volunteers who have no neck and shoulder problems and you are invited to be one of 
these volunteers. The study aims to test 25 patients
5) Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form. If you decide to
Working Together For Heeltt,
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take part you are still free to w ithdraw  at any tim e and w ithou t g iving a reason. A decision 
to  w ithdraw  at any tim e, o r a  decision not to  take part, w ill not affect the standard o f  care you 
receive.
6) What will happen if I have to take part?
If you agree to take part you will be asked to participate in the 3 tests listed below:
a) Test 1
Sitting whilst the therapist palpates the muscle to see if tender knots are present in 
the middle of the muscle.
b) Test 2
Sitting whilst the therapist applies a firm pressure to the skin around the shoulder to 
look for very subtle areas of swelling and thickening within the skin. The skin 
indentation which occurs after pressure will be photographed.
c) Test 3
The therapist will place small electrodes on the surface of the skin to look for 
tightness in the muscles around the neck and shoulder whilst asking you to tense 
your muscles. These electrodes are connected to a small machine called an EMG 
which shows changes in the muscle function. The test is completely harmless and 
painless.
d) You will be asked to be tested 2 times. This will occur at the initial session and 1 
month following the first session.
7) What do I have to do?
There are no restrictions to your lifestyle. The tests will be completed when you 
attend your normal treatment sessions.
8) What is the drug or procedure that is being tested?
There is no drug being tested.
9) What are the alternatives for diagnosis and treatment
Not applicable for volunteers.
10) What are the side effects of any treatment received when taking part?
There are no side effects. Some of the palpation tests may cause discomfort.
117
11) What are the possible disadvantages and risks of taking part?
There are no risks to taking part.
12) What are the possible benefits of taking part?
There is no benefit to you when taking part in the trial.
13) What if new information becomes available?
Not applicable for volunteers.
14) What happens when the research study stops?
Not applicable for volunteers.
15) What if something goes wrong?
All the tests are non invasive and non harmful. In the unlikely event of data being 
collected incorrectly then it may have to be repeated with your permission. If any 
other problems occur you may request that the tests are stopped immediately. If you 
are worried about the tests you may talk to me at any time.
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it. Regardless 
o f this, if  you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated during the course of this study, the normal 
National Health Service complaints mechanisms should be available to you.
16) Will my taking part in this study be kept confidential?
The results o f the tests will be anonymous and during the study the results will be 
kept in a secure area, in line with data protection. The results of the study will be 
used to further the understanding of treating neck pain and frozen shoulder. The 
information should be collected and compiled by 2007. Any photographs taken will 
be destroyed once the data collection is transferred and completed.
17) What will happen to the results of the research study?
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Eventually once compiled the results will be published in a medical journal and 
presented at medical conferences and seminars. Publication of results may include a 
description of symptoms found, however all information will be anonymous
18) Who is organising and funding the research?
The study is being organised by myself with the assistance of Eastern Birmingham 
Primary Care Trust.
19) Who has reviewed this study?
This study has been reviewed by West Birmingham Local Research Ethics 
Committee and the South West Local Research Ethics Committee (in the South West 
o f England).
20) Contact name and number
Stephanie Griffiths MSc., MCSP., FSOM. 0121 415 8594
You can also leave a message at the School of Health Sciences (Physiotherapy),
University o f Birmingham, Edgbaston, Birmingham, B15 2TT.
0121 414 6893
Or Partners in Health Centre, Yardley Green Road, Birmingham 0121 465 2680
Thank you very much for taking part in the study and helping to improve the 
diagnosis and treatment of neck pain and frozen shoulder.
119
Date 28.2.06 Version 5
Information For Frozen Shoulder Patients About the 
Study
1) Study Title
Investigation of trophic changes (skin changes) in C4/5 cervical dysfunction (neck 
pain) and frozen shoulder.
2) Invitation Paragraph
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if  you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part. 
Thank you.
3) What is the purpose of this study?
This research study which began in 2000 involves collecting information and testing 
patients with neck and shoulder problems to help improve diagnosis and treatment.
It is due to finish in 2007. Neck pain and frozen shoulder are common complaints 
that affect patients attending for physiotherapy and can be very difficult to diagnose 
and treat. This study looks at investigating simple changes that occur to the skin 
thickness and muscle tone to see if these simple changes can be used to aid diagnosis 
rather than sending patients for more complex tests.
4) Why have I been chosen?
Patients who have a frozen shoulder or who have neck pain that sends pain into the 
shoulder area will be asked to take part in the study. There will also be a group of 
volunteers who have no neck and shoulder problems. The study aims to test 25 
patients.
5) Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a
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reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive.
6) What will happen if I have to take part?
If you agree to take part you will be asked to participate in the 3 tests listed below:
a) Test 1
Sitting whilst the therapist palpates the muscle to see if tender knots are present in 
the middle of the muscle.
b) Test 2
Sitting whilst the therapist applies a firm pressure to the skin to look for very subtle 
areas o f swelling and thickening within the skin around the shoulder and spine 
including pressing the skin for indentation. The skin changes will be photographed.
c) Test 3
The therapist will place small electrodes on the surface of the skin to look for 
tightness in the muscles around the neck and shoulder whilst asking you to tense 
your muscles. These electrodes are connected to a small machine called an EMG 
which shows changes in the muscle function. The test is completely harmless and 
painless.
d) You will also be asked some general questions about your symptoms. The tests 
last for about 30-40 minutes and will be performed 2 times once before your 
injection, as well as 1 month after your injection. They do not affect your normal 
treatment in any way
7) W hat do I have to do?
There are no restrictions to your lifestyle. The tests will be completed when you 
attend your normal treatment sessions.
8) What is the drug or procedure that is being tested?
The drug used in your treatment is a steroid. Please make sure you read the 
information leaflet you were given when you decided to opt for that treatment.
9) What are the alternatives for diagnosis and treatment
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O f the group of patients with frozen shoulder, a steroid injection is given to help the 
frozen shoulder recover quicker. If injection is not chosen for any other reason, 
physiotherapy will continue just as normal.
10) What are the side effects of any treatment received when taking part?
There are no side effects to the research tests but you may experience slight 
discomfort. The injection leaflet explains the side effects to the steroid injection.
11) What are the possible disadvantages and risks of taking part?
There are some risks to having a steroid injection and there are consequences of the 
local anaesthetic it is mixed with. Please see accompanying information if injection 
is part o f your treatment. There are no risks from the study procedures.
12) What are the possible benefits of taking part?
There is no clinical benefit to you when taking part in the trial. However the chance 
to improve diagnosis for future treatment may have benefits to you if your symptoms 
recur.
13) What if new information becomes available?
Sometimes during the course of a research project, new information becomes 
available about the treatment/drug that is being studied. If this happens, your 
researcher will tell you about it and discuss with you whether you want to continue in 
the study. If you decide to withdraw your researcher will make arrangements for 
your care to continue. If you decide to continue in the study you will be asked to 
sign an updated consent form.
14) What happens when the research study stops?
When the research stops your treatment will continue with your doctor or therapist.
15) What if something goes wrong?
All the tests extra to the normal treatment are non invasive and non harmful. In the 
unlikely event o f data being collected incorrectly then it may have to be repeated 
with your permission. If any other problems occur you may request that the tests are
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stopped immediately. If you are worried about the tests you may talk to me at any 
time.
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it. Regardless 
of this, if  you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated during the course of this study, the normal 
National Health Service complaints mechanisms should be available to you.
16) Will my taking part in this study be kept confidential?
All your physiotherapy records will be kept confidentially as usual, they are not 
needed for the study and so will not be accessed by anyone at any time before, during 
or after the study except when they are needed by the physiotherapist regarding your 
normal treatment. The results of the tests will be anonymous and during the study 
the results will be kept in a secure area, inline with data protection. The results of the 
study will be used to further the understanding of treating neck pain and frozen 
shoulder. The information should be collected and compiled by 2007. Any 
photographs taken will be destroyed once the data collection is transferred and 
completed.
17) What will happen to the results of the research study?
Eventually once compiled the results will be published in a medical journal and 
presented at medical conferences and seminars. Publication of results may include a 
description o f symptoms found, however all information will be anonymous
18) Who is organising and funding the research?
The study is being organised by myself with the assistance of Eastern Birmingham 
Primary Care Trust.
19) Who has reviewed this study?
This study has been reviewed by West Birmingham Local Research Ethics 
Committee and the South West Local Research Ethics Committee (in the South West 
of England).
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20) Contact name and number
Stephanie Griffiths MSc., MCSP., FSOM. 0121 415 8594
You can also leave a message at the School of Health Sciences (Physiotherapy),
University of Birmingham, Edgbaston, Birmingham, B15 2TT.
0121 414 6893
Or Partners in Health Centre, Yardlev Green Road, Birmingham 0121 465 2680
Thank you very much for taking part in the study and helping to improve the 
diagnosis and treatment of neck pain and frozen shoulder.
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Information About the Study For Patients With Neck Pain
1) Study Title
Investigation o f trophic changes (skin changes) in C4/5 cervical dysfunction (neck 
pain) and frozen shoulder.
2) Invitation Paragraph
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would 
like more information. Take time to decide whether or not you wish to take part.
Thank you.
3) What is the purpose of this study?
This research study which began in 2000 involves collecting information and testing 
patients with neck and shoulder problems to help improve diagnosis and treatment.
It is due to finish in 2005. Neck pain and frozen shoulder are common complaints 
that affect patients attending for physiotherapy and can be very difficult to diagnose 
and treat. This study looks at investigating simple changes that occur to the skin 
thickness and muscle tone to see if these simple changes can be used to aid diagnosis 
rather than sending patients for more complex tests.
4) Why have I been chosen?
Patients who have a frozen shoulder or who have neck pain that sends pain into the 
shoulder area will be asked to take part in the study. You have been asked because 
you have a neck problem. There will also be a group of volunteers who have no 
neck or shoulder problems.
5) Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If 
you decide to take part you are still free to withdraw at any time and without giving a
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reason. A decision to withdraw at any time, or a decision not to take part, will not 
affect the standard of care you receive.
6) What will happen if I have to take part?
If you agree to take part you will be asked to participate in the 3 tests listed below:
a) Test 1
Sitting whilst the therapist palpates the muscle to see if tender knots are present in 
the middle of the muscle.
b) Test 2
Sitting whilst the therapist applies a firm pressure to the skin to look for very subtle 
areas of swelling and thickening within the skin around the shoulder including 
pressing the skin for indentation. The skin indentation which occurs after pressure 
will be photographed.
c) Test 3
The therapist will place small electrodes on the surface of the skin to look for 
tightness in the muscles around the neck and shoulder whilst asking you to tense 
your muscles. These electrodes are connected to a small machine called an EMG 
which shows changes in the muscle function. The test is completely harmless and 
painless. They do not affect your normal treatment in any way
7) What do I have to do?
There are no restrictions to your lifestyle. The tests will be completed when you 
attend your normal treatment sessions.
8) What is the drug or procedure that is being tested?
There is no drug involved in your tests.
9) What are the alternatives for diagnosis and treatment
If you do not wish to take part physiotherapy will continue just as normal.
10) What are the side effects of any treatment received when taking part?
There are no side effects to the research tests but you may experience slight 
discomfort.
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11) What are the possible disadvantages and risks of taking part?
There are no risks to taking part.
12) What are the possible benefits of taking part?
There is no clinical benefit to you when taking part in the trial. However the chance 
to improve diagnosis for future treatment may have benefits to you if your symptoms 
recur.
13) What if new information becomes available?
Sometimes during the course of a research project, new information becomes 
available about the treatment/drug that is being studied. If this happens, your 
researcher will tell you about it and discuss with you whether you want to continue in 
the study. If you decide to withdraw your researcher will make arrangements for 
your care to continue. If you decide to continue in the study you will be asked to 
sign an updated consent form.
14) What happens when the research study stops?
When the research stops your treatment will continue with your therapist.
15) What if something goes wrong?
All the tests extra to the normal treatment are non invasive and non harmful. In the 
unlikely event of data being collected incorrectly then it may have to be repeated 
with your permission. If any other problems occur you may request that the tests are 
stopped immediately. If you are worried about the tests you may talk to me at any 
time.
If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you are harmed due to someone’s negligence, then 
you may have grounds for a legal action but you may have to pay for it. Regardless 
of this, if you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated during the course of this study, the normal 
National Health Service complaints mechanisms should be available to you.
16) Will my taking part in this study be kept confidential?
127
All your physiotherapy records will be kept confidentially as usual, they are not 
needed for the study and so will not be accessed by anyone at any time before, during 
or after the study except when they are needed by the physiotherapist regarding your 
normal treatment. The results of the tests will be anonymous and during the study 
the results will be kept in a secure area, inline with data protection. The results of the 
study will be used to further the understanding of treating neck pain and frozen 
shoulder. The information should be collected and compiled by 2007. Any 
photographs taken will be destroyed once the data collection is transferred and 
completed.
17) What will happen to the results of the research study?
Eventually once compiled the results will be published in a medical journal and 
presented at medical conferences and seminars. Publication of results may include a 
description o f symptoms found, however all information will be anonymous
18) Who is organising and funding the research?
The study is being organised by myself with the assistance of Eastern Birmingham 
Primary Care Trust.
19) Who has reviewed this study?
This study has been reviewed by West Birmingham Local Research Ethics 
Committee and the South West Local Research Ethics Committee (in the South West 
of England).
20) Contact name and number
Stephanie Griffiths MSc., MCSP., FSOM. 0121 415 8594
You can also leave a message at the School of Health Sciences (Physiotherapy),
University o f Birmingham, Edgbaston, Birmingham, B15 2TT.
0121 414 6893
Or Partners in Health Centre, Yardlev Green Road, Birmingham 0121 465 2680
Thank you very much for taking part in the study and helping to improve the 
diagnosis and treatment of neck pain and frozen shoulder.
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Centre Number:
Study Number: 2003/327 L 03/06/644 £ %
 ^ i  wwm ^Patient Identification Number for this trial: £  U J jl cJ  =:
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%>dsS°V 
Working Together For Health
CONSENT FORM
Title of Project: Investigation of trophic changes (skin changes) in C4/5 cervical dysfunction 
(neck pain and Frozen shoulder
Name of Researcher: Stephanie Griffiths
Please initial box
1. I confirm that I have read and understand the information sheet d a ted ..............................
(version  ) for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected.
3. I understand that sections o f any of my medical notes may be looked at by
S Griffiths where it is relevant to my taking part in research. I give permission for S Griffiths to 
have access to my records.
4. I agree to take part in the above study.
Name o f Patient Date Signature
Name of Person taking consent Date Signature
(if different from researcher)
Researcher Date Signature
□
□
□
□
1 for patient; 1 for researcher; 1 to be kept with hospital notes
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APPENDIX A2
A2.1 Experiment 1 Kolmogorov Smirnov Significance Values
The information below relates to the results of experiment 1. Following analysis of 
the normal distribution, table A2.1 below shows the Kolmogorov Smirnov 
Significance Values for each group for each outcome tested. Results greater than 
0.05 indicate a normal distribution and those less than 0.05 indicate a non normal 
distribution of scores. Thus the results show that with the exception of surface EMG 
for the frozen shoulder group, (P=0.186), the scores are not normally distributed.
The histogram graphs below also show that the distribution o f scores are generally 
not symmetrical showing a skewed distribution to the left or right.
Table A2.1 Kolmogorov Smirnov Significance Values
(MMST=Modified Matchstick Test, NRS=Numerical Rating Scale, EMG=Surface 
Electromyography of the Maximum Voluntary Contraction)
Outcome Control 
Matched with 
Cervical 
Radiculopathy
Control 
Matched with 
Frozen 
Shoulder
Cervical
Radiculopathy
Group
Frozen
Shoulder
Group
MMST 5 mins 0.000 0.000 0.000 0.001
MMST 10 mins 0.000 0.000 0.000 0.000
NRS 0.000 0.000 0.000 0.000
EMG 0.006 0.032 0.004 0.186
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A2.2 Experiment 1 Histograms for all Outcomes
Histograms for all the outcomes tested in experiment 1 are listed below (figures 
A2.l-A2.16) in the following order:
• Modified Matchstick Test at 5 minutes for all Groups
• Modified Matchstick Test at 10 minutes for all Groups
• Numerical Rating Scale for all Group
• Surface EMG MVC Scores for all Groups
Distribution of Scores for Modified Matchstick Test at 5 and 10 minutes Post 
Compression for All Groups for Experiment 1
Figure A2.1 Histogram of frequency scores for the modified matchstick test at 5 
minutes for the control group matched with the cervical spine group
Histogram
Frequency Scores for Modified Match Stick Test Control Group Matched with Cervical Radiculopathy
2 5 -
2 0 -
10-
5 -
I
Mean = -0.2 
Std. Dev. = 1.064 
N = 30
-4 -2
Modified Matchstick Test Score at 5 minutes (Compression 
Scale -5  to +5)
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Figure A2.2 Histogram of the frequency Scores for the Modified Matchstick 
Test at 5 minutes for the cervical radiculopathy group
H is to g ram
Frequency Scores for Modified Matchstick Test for Cervial Radiculopathy
Mean = 0.1
Std Dev = 1 136 
N = 31
Modified M atchstick T est Score Difference 5 m inutes
Figure A2.3 Histogram showing the frequency scores for the modified 
matchstick Test at 5 minutes for the control group matched with the frozen 
shoulder
Histogram
Control Group Matched with Frozen Shoulder for Modified Matchstick Test
__
__
__
m m - r ------- ................... ' ... y p d .. ...
-6 -4 -3 -2 - 1 0  1
Modified M atchstick  T est S co re  D ifference 5 m inu tes
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Figure A2.4 Histogram showing the frequency scores for the modified 
matchstick test at 5 minutes for the frozen shoulder group
H isto g ram
Modified Matchstick Test Frozen Shoulder Group
12-
10-
8-
6*
2
_ i_0-
2-2 0
Modified Matchstick Test Score Difference at 6 minutes
Mean -  0.59 
Std. Dev. *» 1.701 
N -3 2
Figure A2.5 Histogram of Control Group matched with Cervical Spine Group 
for modified matchstick test at 10 minutes
H is to g ra m
Frequency Scores for Control Matched with Cervical Radiculopathy Group for Modified 
Matchstick Test
OcQ>
3cr2u.
- 3 - 2 - 1 0  1 2  3
Modified Matchstick Test Score Difference 10 minutes
Mean = -0.13 
Std. Dev. « 0.973 
N = 30
134
Figure A2.6 Histogram showing frequency of Modified Matchstick Test scores 
at 10 minutes for the Cervical Radiculopathy Group
Histogram
Freqency Scores for Cervical Radiculopathy Group for Modified Matchstick Test
20 -
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I
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I I ---------- p — .............. ......
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Std. Dev = 1.751 
N * 31
Modified M atchstick Test Score 10 m inutes Post C om pression
Figure A2.7 Histogram showing Frequency Scores for the Modified Matchstick 
Test at 10 minutes for the Control Group Matched with the Frozen Shoulder 
Group
Histogram
Frequency of Modified Matchstick Test for Control Group matched to Frozen Shoulder
Mean * 0.13 
Std. Dev. = 0.973 
N * 30
Modified M atchstick Test Score a t 10 m inutes
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Figure A2.8 Histogram showing Frequency Scores for the Modified Matchstick
Test at 10 minutes for the Frozen Shoulder Group
Histogram
Modified Matchstick Test Frozen Shoulder Group
12
10
2 -
Modified M atchstick Test Score at 5 m inutes
Mean = 0.59 
Std. Dev. = 1.701 
N = 32
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Distribution of Numerical Rating Scale Scores For All Groups For Experiment
1 (Figures A2.9-A2.12)
Figure A2.9 Histogram showing Frequency of Numerical Rating Scale Scores 
for Control Group matched with Cervical Spine Group
Histogram
Frequency Scores for NRS Control Group macted with Cervical Radiculopathy
-2 - 1 0 1 2  
NRS Score
Figure A2.10 Histogram showing Frequency of Numerical Rating Scale Scores 
for Cervical Spine Group
Histogram
Frequency Scores for NRS for Cervical Radiculopathy Group
NRS Score
Mean » 1.74 
Std. Dev. * 2.221 
N * 31
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Figure A 2.ll Histogram showing the frequency of NRS Scores for the Control
Group matched with the Frozen Shoulder Group
Histogram
Frequency Scores for NRS for Control Group mactch ed with Frozen Shoulder
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Mean = 0.03 
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N * 30
NRS Score
Figure A2.12 Histogram showing the frequency of NRS Scores for the Frozen 
Shoulder Group
Histogram
Frequency Scores for NRS for Frozen Shoulder Group
20-
15-
Mean =1.56 
Sid. Dev. = 3.272 
N = 32
NRS Score
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Distribution of Scores for Surface EMG Maximum Voluntary Contraction for 
Experiment 1 for All Groups (A2.13-A2.16)
Figure A2.13 Histogram showing the Frequency of surface EMG MVC Scores 
for Control Group Matched with Cervical Spine
Histogram
Frequency Scores for surface EMG for Control Group Matched with Cervical Radiculopathy
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Figure A2.14 Histogram Showing Frequency of Surface EMG MVC Scores for 
the Cervical Radiculopathy Group
Histogram
Frequency Scores for surface EMG for Cervical Radiculopathy Group
Mean * -47 94 
Std. Dev. *94.114 
N * 31
EMG Maximum Voluntary Contraction (mV)
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Figure A2.15 Histogram showing the Frequency of Surface EMG MVC Scores
for the Control Group Matched with Frozen Shoulder Group
Histogram
Frequency Scores Control Group Matched with Frozen Shoulder Group for surface
14 -
Mean =12.27 
Std. Dev. = 105.974 
N = 30
-200 -100 0 100 200 300 400 500
EMG Maximum Voluntary Contraction (mV)
Figure A2.16 Histogram showing frequency of surface EMG MVC scores for 
the Frozen Shoulder Group
Histogram
Frequency Scores for Frozen Shoulder Group for Surface EMG
Mean = -46.56 
Std. Dev. = 80.981 
N = 32
EMG Maximum Voluntary Contraction (mV)
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A2.3 Experiment 2 Kolmogorov Smirnov Significance Values
Table A2.2 below shows the Kolmogorov Smirnov Significance Values for each 
group for each outcome tested. All values less than 0.05 show that the data is not 
normally distributed. The EMG values for the injection group and non injection 
group at baseline measurement for the MVC EMG outcome are normally distributed, 
as are all EMG values at 4 weeks. The histogram plots shown below for each 
outcome also reflect these findings. (NB MMST=Modified Matchstick Test, 
NRS=Numerical Rating Scale, EMG=Surface EMG).
Table A2.2 Kolmogorov Smirnov Significance Values
Outcome Injection Non
Injection
Control
MMST 5 minutes Baseline 0.019 0.044 0.000
MMST 5 minutes 4 weeks 0.000 0.000 0.000
MMST 10 minutes Baseline 0.025 0.000 0.000
MMST 10 minutes 4 weeks 0.000 0.000 0.000
NRS Baseline 0.006 0.008 0.000
NRS 4 weeks 0.000 0.001 0.000
MVC EMG Baseline 0.186 0.200 0.005
MVC EMG 4 weeks 0.074 0.200 0.200
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A2.4 Experiment 2 Histograms for all Outcomes
Histograms for all the outcomes tested in experiment 21 are listed below (figures 
A2.17-A2.40) in the following order:
• Modified Matchstick Test at 5 minutes at baseline and at 4 weeks for all 
Groups (i.e. Injection, non-injection and control groups) (figures A2.17- 
A2.22)
• Modified Matchstick Test at 10 minutes at baseline and at 4 weeks for all 
Groups (figures A2.23-A2.28)
• Numerical Rating Scale at baseline and at 4 weeks for all Groups (figures 
A2.29-A2.34)
• Surface EMG MVC Scores at baseline and at 4 weeks for all Groups (figures 
A2.37-A2.40)
Distribution of Scores for Experiment 2 for Modified Matchstick Test (MMST) 
at 5 minutes Post Compression for All Groups
Baseline Scores (figures A2.17-A2.19) (i.e. pre-injection week 0)
4 week Scores (figures A2.20-A2.22) (i.e. post injection week 4)
Figure A2.17 Histogram showing the Injection Group Baseline Modified 
Matchstick Test Scores at 5 minutes post compression
Histogram
for Injection Group
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>»o
C0 
3 
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Mean = 0.71 
Std. Dev. = 1.359 
N = 170-*
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MMST Score 5 m inutes post com pression at Baseline
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Figure A2.18 Histogram showing the Non Injection Group Baseline Modified
Matchstick Test Scores at 5 minutes
Histogram
for Non Injection Group
Mean = 0.2 
Std. Dev. = 2.3 
N = 10
MMST Score 5 m inutes post com pression at Baseline
Figure A2.19 Histogram showing the Control Group Baseline Modified 
Matchstick Test Scores at 5 minutes post compression
Histogram
20-
2 15-
for Control Group
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MMST S core 5 m inutes p ost com pression at Baseline
Mean = 0.4 
Std. Dev. = 1.003 
N = 30
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Figure A2.20 Histogram showing the Injection Group Modified Matchstick Test
Scores at 5 minutes post compression at 4 weeks
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Figure A2.2I Histogram showing the Injection Group Modified Matchstick Test 
Scores at 5 minutes post compression at 4 weeks
Histogram
For Non Iryection Group
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Figure A2.22 Histogram showing the Control Group Modified Matchstick Test
Scores at 5 minutes post compression at 4 weeks
Histogram
for Control  Group
1 2  3 4
MMST 5 m inutes p ost com pression  a t 4 w eeks
Mean = 0.57 
Std. Dev. = 1.073 
N = 30
Histograms for Modified Matchstick Test Scores 10 minutes Post Compression 
at Baseline for All Groups
Baseline Scores (figures A2.23-A2.25)
4 week Scores (figures A2.26-A2.28)
Figure A2.23 Histogram showing the Baseline Injection Group Modified 
M atchstick Test Scores at 10 minutes post compression
Histogram
for Injection Group
MMST 10 minutes post compression at Baseline
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Figure A2.24 Histogram showing the Baseline Non-Injection Group Modified
Matchstick Test Scores at 10 minutes post compression
12
U_ 3 -
Histogram
M#an = -0 6  
Std Dev = 1 955 
N * 10
MMST 10 minutes post compression at Baseline
Figure A2.25 Histogram showing the Baseline Control Group Modified 
Matchstick Test Scores at 10 minutes post compression
Histogram
for Control Group
0 1 2  3
MMST Score 10 minutes Post com pression at Baseline
Mean = 0 23 
Std Dev. = 0.774 
N * 3 0
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Figure A2.26 Histogram showing the Modified Matchstick Test Scores at 10
minutes post compression for the Injection Group at 4 weeks
Histogram
for Injection Group
12-
10-
Mean = 0.06 
Std. Dev. = 2.076
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MMST Score 10 minutes Post Compression at 4 weeks
Figure A2.27 Histogram showing the MMST Scores at 10 minutes post 
compression for the Non Injection Group at 4 weeks
Histogram
for Non Injection Group
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Figure A2.28 Histogram showing the MMST Scores at 10 minutes post
compression for the Control Group at 4 weeks
H istogram
for Control Group
Mean = 0 23 
Std Dev = 0.626 
N = 30
MMST 10 m inutes post compression at 4 weeks
Histograms showing the frequency of NRS Scores for Experiment 2 at Baseline 
and 4 weeks for All Groups. Baseline Scores (figures A2.29-A2.31), Scores at 4 
weeks (A2.32-A2.34)
Figure A2.29 Histogram showing Baseline NRS Scores for the Injection Group
Histogram
for Injection Group
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Figure A2.30 Histogram showing Baseline NRS Scores for the Non-Injection
Group
Histogram
For Non Injection Group
Mean = 1 4 
Std Dev =2547 
N = 10
B aseline NRS S cores
Figure A2.31 Histogram show ing Baseline NRS Scores for the Control Group
Histogram
for Control Group
Mean = 0.43 
Std. Dev. = 0.774 
N = 30
Baseline NRS Scores
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Figure A2.32 Histogram showing NRS Scores for the Injection Group at 4
weeks
Histogram
For Injection Group
Mean = 0.53 
Std. Dev. * 2.853 
N = 17
NRS S c o r e s  a t  4 w eek s
Figure A2.33 Histogram showing NRS Scores for the Non-Injection Group at 4 
weeks
Histogram
for Non Injection Group
Mean = 0.1 
Std. Dev = 0.994 
N = 10
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NRS Scores 4 weeks
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Figure A2.34 Histogram showing NRS Scores for the Control Group at 4 weeks
Histogram
for Control Group
Mean = 0.3 
Std. Dev. = 0.596 
N = 30
-0.5 0 0.5 1 1.5 2 2.5
NRS S co res 4 w eeks
Histograms showing Surface EMG MYC Scores for Experiment 2 at Baseline 
and 4 weeks for all Groups
Baseline Scores (figures A2.35-A2.37), 4 week Scores (figure A2.38-A2.40)
Figure A2.35 Histogram showing Baseline EMG MVC Scores for the Injection 
Group
Histogram
Injection Group
Baseline EMG MVC Scores
151
Figure A2.36 Histogram showing Baseline EMG MVC Scores for the Non-
Injection Group
Histogram
for Non injection Group
Mean = -38
Std Dev. = 111.149
N = 10
-200 -100 0 100 200 
Baseline EMG MVC Scores
Figure A2.37 Histogram showing Baseline EMG MVC Scores for the Control 
Group
Histogram
for Control Group
Mean = -38.4 
Std. Dev. = 99.301 
N = 30
Baseline EMG MVC Scores
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Figure A2.38 Histogram showing EMG MVC Scores for the Injection Group at
4 weeks
Histogram
Injection Group
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EMG MVC Scores 4 weeks
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Figure A2.39 Histogram showing EMG MVC Scores for the Non-Injection 
Group at 4 weeks
Histogram
for Non Injection Group
Mean = -6.4 
Std. Dev. = 55.724 
N = 10
EMG MVC Scores at 4 weeks
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Figure A2.40 Histogram showing EMG MVC Scores for the Control Group at 4
weeks
Histogram
for Control Group
Mean = -12.87 
Std. Dev. = 33.947 
N = 30
-100 -75 -50 -25 0 25 50
EMG MVC Scores at 4 weeks
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A2.5 Interquartile Ranges and Median Values for Experiment 1
As discussed in the main thesis because the data was primarily ordinal data and non 
normally distributed it was inappropriate to use mean and standard deviation to 
describe the statistics, therefore interquartile ranges and percentiles were used. The 
median and interquartile ranges are shown in table A2.3 and A2.4 below. Percentiles 
can be used when there is at least a 10 point scale (Sim and Wright 2000). In the 
case of the data from this study there was a range of values from -5  to + 5 when 
using the Modified Matchstick Test or when using the Numerical Rating Scale there 
was a range from -10  to +10 and thus it was possible to use percentiles to describe 
the data. (N.B. The positive and negative aspects of the scales do not negate each 
other for the purpose of using percentiles) (Holder 2007). The interquartile range 
(IQR) is a measure o f variability, it is the range between the lower and the upper 
quartiles. The box plots below provide a visual representation of the data in tables 
A2.3 and A2.4. The median value is represented by the thick black line in the centre 
of the beige box, with the projections from the box reaching to the upper and lower 
quartiles. Starred values represent extreme data.
Table A2.3 Median Values and the Interquartile ranges for the Cervical 
Radiculopathy Group and the Matched Control
(MMST=Modified Matchstick Test, NRS=Numerical Rating Scale, 
MVC=Maximum Voluntary Contraction measured by surface EMG in millivolts, 
IQR=interquartile range)
MMST 
5 minutes
MMST 
10 minutes
NRS (0-10) MVC (mV)
Median IQR Median IQR Median IQR Median IQR
Control Group 0.00 0 0.00 0 0.00 0 -10.50 113
Cervical
Radiculopathy
Group
0.00 1 0.00 0 1.00 4 -16 109
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Table A2.4 Median Values and the Interquartile ranges for the Frozen Shoulder 
Group and the Matched Control
(MMST=Modified Matchstick Test, NRS=Numerical Rating Scale,
MVC=Maximum Voluntary Contraction measured by surface EMG in millivolts, 
IQR=interquartile range)
MMST 
5 minutes
MMST 
10 minutes
NRS (0-10) MVC (mv)
Median IQR Median IQR Median IQR Median IQR
Control
Group
0.00 0 0.00 0 0.00 0 -5.50 107
Frozen
Shoulder
Group
0.00 2 0.00 2 0.00 3 -51.50 69
Figure A2.41 Box Plot showing the interquartile range for the cervical 
radiculopathy group and the control group for the modified matchstick test at 5 
minutes.
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Figure A2.42 Box Plot showing the interquartile range for the frozen shoulder
group and the control group for the modified matchstick test at 5 minutes.
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Figure A2.43 Box Plot showing the interquartile range for the Cervical 
Radiculopathy group and the Control group for the Modified M atchstick Test 
a t 10 minutes.
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Figure A2.44 Box Plot showing the interquartile range for the Frozen Shoulder
Group and the Control group for the Modified Matchstick Test at 10 minutes
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Figure A2.45 Box Plot showing the interquartile range for the Cervical 
Radiculopathy Group and the Control Group for the Numerical Rating Scale
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Figure A2.46 Box Plot showing the interquartile range for the Frozen Shoulder
Group and the Control Group for the Numerical Rating Scale
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Figure A2.47 Box Plot showing the interquartile range for the Cervical 
Radiculopathy Group and the Control Group for the EMG Maximum 
Voluntary Contraction
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Figure A2.48 Box Plot showing the interquartile range for the Frozen Shoulder
Group and the Control Group for the EMG Maximum Voluntary Contraction
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Section A2.6 Interquartile Ranges and Median Values for Experiment 2
The interquartile ranges and the median values are shown in table A2.6 for each 
group from experiment 2, for each of the 3 outcomes measured. The range of EMG 
scores is greater in the control and non injection group at baseline which reduces at 4 
weeks. However the reverse is true for the injection group.
Table A2.6 Median values and the interquartile ranges for all 3 groups at 
baseline and measurements at 4 weeks
(N.B. MMST=Modified Matchstick Test, NRS=Numerical Rating Scale, 
MVC=Maximum Voluntary Contraction measured by surface EMG in millivolts, 
IQR=interquartile range).
Injection Group Non Injection 
Group
Control Group
Median IQR Median IQR Median IQR
MMST 5 minutes 
Baseline
0.00 2 0.00 3 0.00 0
MMST 5 minutes 4 
weeks
0.00 1 0.00 3 0.00 0
MMST 10 minutes 
Baseline
0.00 3 0.00 1 0.00 0
MMST 10 minutes 4 
weeks
0.00 1 0.00 0 0.00 0
NRS Baseline 0.00 4 0.00 2 0.00 0
NRS at 4 weeks 0.00 2 0.00 0 0.00 0
MVC EMG (mv) 
Baseline
-48.00 68 -64.00 169 -5.50 107
MVC EMG (mv) at 4 
weeks
12.00 95 2.00 87 -2.00 40
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Figure A2.49 Box Plot showing the baseline interquartile range and median
values for the Modified Matchstick Test at 5 minutes for all 3 groups (Injection,
Non-Injection and Control).
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Figure A2.50 Box Plot showing the interquartile range and median values at 4 
weeks for the Modified Matchstick Test at 5 minutes for all 3 groups (Injection, 
Non-Injection and Control)
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Figure A2.51 Box Plot showing the baseline interquartile range and median
values for the Modified Matchstick Test at 10 minutes for all 3 groups
(Injection, Non-Injection and Control).
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Figure A2.52 Box Plot showing the interquartile range and median values at 4 
weeks for the Modified M atchstick Test at 10 minutes for all 3 groups 
(Injection, Non-Injection and Control)
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Figure A2.53 Box Plot showing the interquartile range and median values at
baseline for the Numerical Rating Scale for all 3 groups (Injection, Non-
Injection and Control)
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Figure A2.54 Box Plot showing the interquartile range and median values at 4 
weeks for the Num erical Rating Scale for all 3 groups (Injection, Non-Injection 
and Control).
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Figure A2.55 Box Plot showing the interquartile range and median values at
baseline for the Maximum Voluntary Contraction Measured by surface EMG
for all 3 groups (Injection, Non-Injection and Control).
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Figure A2.56 Box Plot showing the interquartile range and median values at 4 
weeks for the M aximum Voluntary Contraction M easured by surface EMG for 
all 3 groups (Injection, Non-Injection and Control).
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Section A2.7 Sensitivity Calculations
Sensitivity Calculations are based on the following Formula (Bland 2000)
Number who are both disease positive and test positive 
Number who are disease positive
Cervical Radiculopathy Group Sensitivity Calculations 
Modified Matchstick Test at 5 minutes
2 /3 1 = 0 .0 6
Modified Matchstick Test at 10 minutes
5 /31= 0 .16
Numerical Rating Scale with Algometry
1 2 /3 1 = 0 .3 9
Maximum Voluntary Contraction Surface EMG
At 0.5 Cut off Sensitivity = 5/31 =0.16 
At 0.75 Cut off Sensitivity= 13/ 31=0.42
Frozen Shoulder Group Sensitivity Calculations 
Modified Matchstick Test at 5 minutes
10 / 32= 0.31
Modified Matchstick Test at 10 minutes
9 / 32= 0.28
Numerical Rating Scale with Algometry
13 /32=  0.41
Maximum Voluntary Contraction Surface EMG
At 0.5 Cut off Sensitivity = 8 / 32=0.25 
At 0.75 Cut off Sensitivity= 19 / 32=0.59
A2.8 Specificity Calculations
Specificity Calculations are based on the following formula (Bland 2000)
Number who are both disease negative and test negative 
Number who are disease negative
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Cervical Radiculopathy Group Specificity Calculations
Modified Matchstick Test at 5 minutes
29/30 =0.96
Modified Matchstick Test at 10 minutes
30/30=1
Numerical Rating Scale with Algometry
28/30=0.93
MVC with Surface EMG cut off at 0.5
27/30=0.90
MVC with Surface EMG cut off at 0.75
21/30=0.70
Frozen Shoulder Group Specificity Calculations 
Modified Matchstick Test at 5 minutes
30/30=1
Modified Matchstick Test at 10 minutes
29/30=0.96
Numerical Rating Scale with Algometry
27/30=0.9
MVC with Surface EMG cut off at 0.5
28/30=0.93
MVC with Surface EMG cut off at 0.75
24/30=0.80
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A2.9 Experiment 1 Mean, standard Deviation, Standard Error of the Mean for 
surface EMG
This section shows the mean, standard deviation and standard error o f the mean for 
EMG values (for comparison purposes only). (NB Scores represent the difference 
between the affected and the unaffected sides.
Table A2.7 Mean, Standard Deviation and Standard Error for the Maximum 
Voluntary Contraction surface EMG for the Control Groups Versus the 
Cervical Radiculopathy and Frozen Shoulder Group
Control Vs Cervical Radiculopathy 
Group
Control Vs Frozen Shoulder Group
Mean EMG Control Group -28.00 Mean EMG Control Group 12.27
Standard Deviation 
EMG Control Group
102.835 Standard Deviation 
EMG Control Group
105.974
Control Group Standard Error 
of the Mean
18.775 Control Group Standard Error 
o f the Mean
19.348
Mean EMG Cervical 
Radiculopathy
-47.94 Mean EMG Frozen Shoulder -46.56
Standard Deviation
EMG Cervical Radiculopathy
94.114 Standard Deviation EMG 
Frozen Shoulder
80.981
Standard Error of the Mean 
Cervical Radiculopathy Group
16.903 Standard Error o f the Mean 
Frozen Shoulder Group
14.316
168
Figure A2.61 Mean EMG Scores for the Cervical Radiculopathy Group and
matched control
_____ I____
Control Group Cervical Radiculopathy Group
Control Group Vs Cervical Radiculopathy Group
Error bars: ■*■/- 2.00 SE
Figure A2.62 M ean EM G Scores for the Frozen Shoulder Group and matched 
Control
Control Group Frozen Shoulder Group
Control Vs Frozen Shoulder Group
Error bars: +/- 2.00 SE
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A2.10 Experiment 2 Mean, Standard Deviation and Standard Error of the 
Mean
The mean, standard deviation and standard error of the mean for the EMG values for 
experiment 2 are provided for comparison purposes only. The data is shown in table 
A2.10 for the control, injection and non-injection groups.
Table A2.8 Mean, Standard Deviation and Standard Error for the MVC 
measured with and Surface EMG for all 3 groups.
Group Control Injection Non Injection
Baseline 4 weeks Baseline 4 weeks Baseline 4 weeks
Mean MVC 
EMG
12.27 3.47 -56.00 48.53 -38.00 -6.40
Standard 
Deviation 
MVC EMG
105.974 36.211 73.080 87.607 111.149 55.724
Standard Error 
MVC EMG
18.130 6.198 17.724 21.248 35.148 17.621
Figure A2.7 Mean Values for the Surface EMG maximum voluntary 
contraction at Baseline and at 4 weeks for the Injection , Non-injection and 
Control Group
_  Difference in MVC 
Scores Before Injection 
Difference in MVC 
9  Scores 4 weeks after 
Injection
Injection Group Non Injection Group Control Group
G roup
Error bars: +/-2.00SE
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